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The main reasons for control of antimicrobial drugs are to improve medical care, 
to limit the emergence and spread of resistant strains, and to contain costs. 
In developed countries, 30% of all patients receive one or more antimicrobial 
drugs during their hospital stay. Antimicrobial drug sales in the U.S. rose from $ 
3.7 billion in 1988 to $ 5.6 billion in 1993. Although there is some evidence that 
the magnitude of overuse of antimicrobial drugs is larger in developing 
countries, there have been very few studies (1). Antimicrobial drugs account for 
the largest proportion of all drugs, ranging from 13 to 37% of these purchases 
by hospitals in Europe (2). In the Netherlands, national expenses for 
antimicrobial drugs amounted to Dfl 180 million in 1990. 
In the seventies, Kunin identified the new cephalosporins as "drugs of fear", 
which means: potent drugs with little toxicity being given to any patient with 
fever (3). For the past seven years, the quinolones have been (mis)used to a 
similar exent (4, 5). Reports of overuse and misuse of antimicrobial drugs have 
been published from all over the world for more than thirty years (1, 3, 5-8). 
Microbial resistance to antimicrobial drugs has been increasing since the first 
years of their clinical use. In 1941 virtually all Staphylococcus aureus (SA) 
strains were susceptible to penicillin G, whereas today 80 to 95% of strains are 
penicillin resistant. Moreover, after the successful development of penicillinase-
resistant penicillins, methicillin-resistant SA (MRSA) resistant to all beta-lactams 
emerged. Remaining MRSA-free is at present an increasing challenge to many 
hospitals in the Netherlands. In other countries, due to a high prevalence of 
MRSA, empiric therapy for severe SA infection is limited to less active, 
potentially toxic and expensive drugs. Bacteria have become resistant to 
antimicrobial drugs as a result of chromosomal changes or the exchange of 
genetic material via plasmids and transposons. Resistant genes can be 
transferred from commensals to pathogenic bacteria. For the last forty years, 
researchers and the pharmaceutical industry have fought back by developing 
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and promoting more than one hundred and fifty new broad-spectrum 
antimicrobial drugs. Many of these promising compounds, however, have 
become ineffective by now. 
Several types of evidence link antimicrobial use to microbial resistance (9). In 
the community, geographical differences in patterns of antimicrobial drug use 
correlate with the distribution of resistant strains: for example, the relatively high 
resistance to macrolides of streptococci in France is explained by the country's 
extensive use of oral macrolides in the past. In hospitals, a series of studies have 
shown a relationship between hospital antimicrobial drug consumption and the 
frequency of microbial resistance (10-12). Within hospitals, a higher frequency 
of resistance is found in areas of high consumption such as Intensive Care Units 
(ICU). Selective Decontamination of the Digestive tract (SDD), although still 
controversial, was quickly adopted by many ICU's. At present there is strong 
suspicion that SDD leads to colonization with resistant gram-negative bacteria 
and/or gram-positive pathogens such as enterococci, MRSA and 
Staphylococcus epidermidis (13, 14). Resistant strains in the ICU constitute a 
reservoir that is spread to step-down units in the hospital. In nursing homes, 
newly admitted elderly are colonized with resistant flora from referring hospitals. 
In addition, at community level, antimicrobial drug use in the veterinary sector 
has become of particular concern. In the Netherlands, the rapid emergence of 
quinolone resistance in Campylobacter jejuni strains isolated from poultry 
products and human stools was traced to the extensive use of enrofloxacin in 
the poultry industry (15). Recently, the worldwide problem of widespread 
antimicrobial resistance has received the attention of scientific journals (16) and 
made scientists send out alarming messages into the world community (17). 
Magazine articles (18) have depicted the downfall of the miracle drugs in a war 
report style. 
Appropriate use of antimicrobial drugs in humans and control of veterinary 
antimicrobial drug use are believed to delay and prevent bacterial resistance. In 
several hospitals, reduction of the use of an antimicrobial drug resulted in the 
decrease of resistant strains (10,19, 20). 
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In the future the threat of microbial resistance will become the major tool of the 
infectious diseases community to implement antimicrobial drug policies. In the 
eighties, the introduction of budget systems in the United States - and to a lesser 
extent in some European countries - has been the major incentive to the 
development of antimicrobial drug policies (21). There are numerous reports in 
the literature indicating that intensifying antimicrobial drug policies results in 
cost containment. This is mainly due to the lower cost of directed therapy with 
narrow spectrum antimicrobial drugs and to the shorter duration of perioperative 
prophylaxis. 
In the Netherlands, before the start of this study, there had been a limited 
number of studies on the quality of use of antimicrobial drugs and on the effect 
of antimicrobial drug policies. Ten years earlier, Hekster had studied quantitative 
utilization in defined daily doses (DDD) in a department of urology and 
presented general guidelines (22). Using this DDD methodology, a comparison 
of quantitative use between Dutch, Swedish and a Belgian university hospital 
was performed (23). Other authors studied compliance with guidelines (24, 25). 
Consultant microbiologists had focused on hospital antimicrobial drug use and 
the relation to bacterial resistance (11, 26). The national situation of the use of 
hospital formularies was studied by van Everdingen in 1988. Although we 
knew from the European study on the use of aminoglycosides (27) that 
consumption and resistance in Dutch hospitals compared favourably with other 
countries, we were not confident about the quality of antimicrobial drug 
prescribing. In the University Hospital of Nijmegen, the costs of antimicrobial 
drug consumption had doubled from Dfl. 1.5 million in 1982 to 3.0 million in 
1988. This was the major reason for the board of the hospital to become 
interested in cost containment for these drugs. A proposal from our side to 
investigate antimicrobial drug prescribing was granted, so that we could start 
the investigations in October 1989. The results of these studies are presented in 
this thesis. 
We addressed the following questions: 
1. Is it possible to measure antimicrobial drug consumption in terms of 
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quality, quantity (DDDs), and costs in the main departments of a 
university hospital? In chapter I, an educational description of the 
principles of antimicrobial therapy that form the basis of the quality 
evaluation is given. Chapter II describes the method of quality 
evaluation based on established criteria, and chapter III the cost 
calculation method, both of which were developed for the study. The 
quality of antimicrobial therapy is dependent on the quality of 
microbiological diagnosis. We developed an analoguous quality evaluation 
method in order to analyse the appropriateness of the requests sent 
to the microbiology laboratory by clinicians; it was applied in a surgical 
department (Chapter V). 
2. Is it possible to improve quality of use by a number of interventions 
tailored on the different specialties (surgery, internal medicine) and 
targeted to the type of inappropriate use identified (prophylaxis or 
therapy)? Three chapters deal with the study in surgical 
departments. In chapter IV we describe the results of the 
intervention study in the departments of surgery, gynaecology and 
orthopaedics. In chapter VI the crucial role of the anaesthetist in 
prophylaxis is stressed, and in chapter VII we describe the impact of 
the intervention on the timing of surgical prophylaxis. 
The intervention study in internal medicine is dealt with in chapters 
VIII and IX. In chapter VIII the effect of an educational 
programme and order form in this department are described, and in 
chapter IX the feasibility of the antibiotic order is analysed. 
3. Does optimization of quality result in cost containment? In chapter 
IV, the cost savings obtained in surgical departments are analysed. 
Chapter VIII deals with the cost aspects in internal medicine. 
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CHAPTER I 
The principles of antimicrobial therapy. 
1С Gyssens and JWM van der Meer 
Published as: Considerations in providing antibiotic therapy. The APUA 
Newsletter 1992, winter:3-5. 
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Abstract 
Antimicrobial therapy is causal therapy directed against microorganisms. For the 
decision to start antimicrobial therapy we should know whether the patient has 
indeed an infection and if so, whether it is wise to treat him with antimicrobial 
drugs. The complex interactions between pathogen and host, between 
pathogen and the commensal flora, and between antimicrobial drug and micro-
organisms are reviewed. The activity of antimicrobial drugs and the resistance of 
the microorganisms result in either susceptibility or non-susceptibility of the 
microorganisms. When antimicrobial therapy is initiated, the spectrum of the 
antimicrobial drug chosen should be broad enough to cover the possible 
causative organisms associated with the clinical picture. This is called empiric or 
provisional therapy. After preliminary microbiology results become known, the 
therapy can be progressively adjusted to antimicrobial drugs that have a less 
broad spectrum. The final adaptation occurs when all culture results are known. 
This is called definitive or directed therapy. The process is described as 
"streamlining". The motives for combination of antimicrobial drugs are discussed. 
The rapidity of response is dependent on the causative microorganism, on host 
defense factors, and on the therapy chosen. The duration of treatment can be 
determined with parameters of response, and is mostly based on clinical 
experience with similar infections. Every physician should be aware that 
antimicrobial treatment has immediate implications for the commensal flora, and 
that, even if he prescribes antimicrobial drugs appropriately, he contributes to 
induction of resistance. Prudence in prescribing is essential. 
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Introduction 
Antimicrobial therapy is causal therapy directed against microorganisms. For the 
decision to start antimicrobial therapy we should answer the following 
questions: 
1. Are the signs and symptoms due to an infection? We need the patient's 
history, physical examination and the results of additional investigations. 
2. What are the most likely causative organisms? Based on knowledge of 
infectious diseases it is possible to list organisms, factors such as 
symptomatology, organ localization and whether the infection is community or 
hospital acquired. The next step is to decide whether microbiological 
investigations should be carried out. For severe infections (hospitalized patients) 
this is the rule. The Gram stain of an appropriately taken specimen can provide 
preliminary identification of etiologic microorganisms while awaiting culture 
results. 
3. Can the causative organism be treated with antimicrobial drugs? The infection 
may be at a site where no active concentrations of the drug can be achieved (for 
example an infected joint prosthesis); surgical intervention is indicated in such 
cases. In rare cases, total antimicrobial resistance may make therapy impossible. 
4. Is it necessary to combat the causative organisms with antimicrobial drugs? 
(in other words: what is the rationale for treatment?) Some bacterial infections 
like impetigo, furunculosis and secondary infected decubital ulcers are not 
necessarily treated with antibiotics. 
5. Which drug do we choose, which dosage regimen, which route of 
administration? If it is highly likely that the symptomatology is due to a bacterial 
infection which needs antimicrobial treatment, a choice should be made from the 
vast armamentary of antimicrobial drugs. The choice of initial therapy is 
determined by the most likely microorganisms that cause the infection. In 
practice, the choice should already be limited by the formulary list of the 
hospital. Dosage regimens are based on pharmacodynamic characteristics of the 
drugs. 
6. How are we going to judge the effect of therapy, and how long are we going 
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to treat the patient? There are few hard data on the optimal duration of 
antimicrobial drug treatment. As for the judgement of effect, duration is mostly 
based on clinical experience with similar infections. 
Before discussing choice, dosage regimen and duration of treatment, one should 
take in to consideration the large number of interactions between therapy, the 
host (the patient), the causative organism (the pathogen) and the commensal 














Figure 1 - The pyramid of infectious diseases 
The interactions between pathogen and host 
One important interaction between pathogen and host is virulence, which may 
be defined as the capacity of an organism to compete with surrounding flora, to 
damage tissues and to withstand host defense mechanisms. Virulence determines 
not only the number of individuals that become ill after exposure to the 
pathogen, but also the severity of disease. If host defense mechanisms are 
defective, pathogens of low virulence may cause disease. 
An intact surface of skin and mucous membranes, as well as the humoral and 
cellular defense mechanisms form together the normal resistance to infection (1). 
In patients with impaired host defense, infections usually run a more severe 
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course. This has consequences for the selection of an antimicrobial drag, dosage 
regimen and duration of therapy, because the drugs have to compensate for the 
defects in host defense. For example, aminoglycosides alone are not very 
effective in granulocytopenic patients with Gram-negative infections (2). Higher 
dosages and different dosage regimens are necessary for a therapeutic effect in 
neutropenic animals (3). 
For the choice of the initial antimicrobial therapy it is good to realize that certain 
defects in host defense will predispose to certain infections (1). 
The pathogen and the commensal flora 
The interactions between pathogenic and commensal flora can be described as 
colonization and colonization resistance. To be able to colonize, microorganisms 
need a series of properties. In recent years the understanding of these properties 
has increased and therapeutic modalities to interfere with such mechanisms have 
been investigated. 
Colonization resistance (or microbial antagonism) (4) can be defined as the 
capacity of commensal microorganisms to limit colonization and outgrowth of 
other, potentially pathogenic microorganisms. An example of colonization 
resistance is found in the gastrointestinal tract, where the anaerobes grow out to 
concentrations of 10* Vg of faeces and do not allow the aerobes to grow out to 
more than 10'-10*/g. This antagonism is probably due to a competition for 
nutrients. Anaerobes limit the outgrowth of the aerobes; if we eliminate the 
anaerobes by means of antibiotics, the aerobes will grow out to 10* Vg. When 
both anaerobes and aerobes are suppressed by antibiotics, drug-resistant 
aerobes from the food will colonize and grow. Thus, antimicrobial therapy may 
produce dramatic changes in the colonizing microflora. Studies by Vollaard et al 
(5), have demonstrated that almost any antimicrobial drug will affect 
colonization resistance. For certain patients, such as neutropenic patients, it 
seems that secondary infections are prevented if the effects of both prophylactic 
and therapeutic antibiotics on colonization resistance are taken into account. 
It is unknown to what extent colonization resistance plays a role in the 
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emergence of resistant microorganisms in the hospital. 
The interaction between the antimicrobial drug and microorganisms 
The activity of antimicrobial drugs and the resistance of the microorganisms 
result in either susceptibility or non-susceptibility of the microorganisms. 
Culture results and in vitro susceptibility tests will be used for guidance. 
However, the results of susceptibility testing cannot be translated to the in vivo 
situation in an unrestricted fashion. The data on effective concentrations of 
antimicrobial drugs in vivo are very limited and more studies in this particular 
area are needed. Nevertheless, in vitro data are clinically useful. Moreover, 
antimicrobial therapy is the only form of treatment in which we can make a 
reasonable in vitro prediction of the in vivo effect. 
In recent years, our insight in the pharmacodynamic aspects of antimicrobial 
treatment (e.g., the in vivo effect of the drug on its target, the microorganism) 
has increased considerably. For ß-lactam antibiotics we now know that the 
antimicrobial effect is mainly time-dependent and not very much dose-
dependent (prolonged exposure to these drugs is necessary). Moreover, when 
antimicrobial concentrations become very low, bacterial regrowth occurs 
immediately: there is no "postantibiotic effect" (6). Aminoglycosides however, 
have a concentration-dependent and not time-dependent antimicrobial effect, 
and a strong "postantibiotic effect" (6), i.e. the microorganisms do not 
immediately regrow after elimination of the drug. Consequently, we tend to give 
more frequent dosages of ß-lactam antibiotics, rather than higher dosages, in 
infections that are difficult to treat; and less frequent, higher dosages of 
aminoglycosides are chosen (see also below the paragraphs dealing with 
toxicity). 
Many mechanisms of antimicrobial resistance have been elucidated in recent 
years (table 1). The relative contribution of the various mechanisms for in-
hospital situations as well as in the individual patient is not known, but studies 
have demonstrated that there is a direct relationship between the total amount 
of a certain antibiotic used in a particular hospital during a certain period and 
the amount of resistant strains that emerge (7, 8). 
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Therefore, it is no surprise that restrictive use of antibiotics in hospitals and 
nursing homes leads to a reduction in resistance. In our opinion, limitation of 
veterinary use of antibiotics is also an important issue (9,10). International 
concern about emergence of resistance has led to the foundation of the Alliance 
for the Prudent Use of Antibiotics (APUA). 
Initial therapy and adaptation to definitive therapy 
When antimicrobial therapy is initiated, the etiologic microorganism is generally 
Table 1 - Origins of resistant microorganisms 
Resistant microorganisms: 
1. were already resistant before treatment 
2. became resistant during therapy due to: 
a. enzyme induction 
b. mutation 
с adaptation 
d. chromosomal transfer of resistance 
e. extrachromosomal transfer of resistance 
3. took the place of sensitive microorganisms during or after treatment 
unknown. The spectrum of the antibiotic chosen should be broad enough to 
cover the possible causative organisms associated with the clinical picture. This 
is called empiric or provisional therapy. After preliminary microbiology results 
become known, the therapy can be progressively adjusted to antimicrobial 
drugs that have a less broad spectrum. The final adaptation occurs when all 
culture results are known. This is called definitive or directed therapy. This 
process is described as "streamlining" in the literature (11). There is not only a 
change from broad spectrum to narrow spectrum, but also from combination 
therapy to single drug therapy, and from newer to older drugs. This strategy 
generally results in cost containment. Additional advantages of streamlining are: 
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1. Large experience with older drugs for similar infections. 
2. Prevention of resistance; by switching to a narrow spectrum antibiotic we 
decrease selection pressure, and by switching to a conventional ("old") 
drug, we limit exposure to new broad spectrum drugs, thereby preventing 
emergence of resistance to the latter drugs. 
Table 2 - The choice of antimicrobial drugs for treatment 
The optimal antimicrobial drug for treatment 
1. is highly active against the (suspected) causative organism 
2. reaches effective concentrations at the site of infection 
3. has very little toxicity 
4. does not lead to emergence of resistant microorganisms 
- in the patient 
- in the environment 
5. can be administered via the desired route 
6. is economic 
Combination of antimicrobial drugs 
Combination of antimicrobial drugs leads to a broadening of the antimicrobial 
spectrum, thereby increasing the selection pressure on the microflora. 
Although antibiotics are often combined aiming for a synergistic (potentiating) 
effect, our knowledge of synergism and antagonism in vivo is very limited. 
Combining antimicrobial drugs generally does not lead to dose reduction, but to 
more toxicity and a greater difficulty in judging to which drug a certain side 
effect (e.g. a rash) has to be attributed. 
There is however a limited number of indications for combined therapy: 
1. Initial, "blind" (empiric) therapy. This broad spectrum combination should be 
streamlined as soon as possible. 
2. Mixed infections. Infections caused by multiple organisms (e.g. aerobes and 
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anaerobes) may necessitate combination therapy to cover the whole 
spectrum. 
3. Synergistic combination. Synergism is proven for the combination of a 
penicillin and an aminoglycoside in endocarditis caused by viridans 
streptococci and enterococci; the combination of trimethoprim with 
sulphamethoxazole (cotrimoxazole) against a variety of pathogens; the 
combination of amphotericin В and 5 flucytosine for the treatment of 
cryptococcal meningitis. Reduced dosages are used in the combinations 
cotrimoxazole and amphotericin В and 5 flucytosine. 
4. Prevention of resistance of the causative microorganism during treatment. 
Resistance may occur because the microorganism is able to adapt to the 
drug (e.g. Mycobacterium tuberculosis) or because the drug readily induces 
resistance when used in monotherapy (e.g. rifampicin, trimethoprim, fusidic 
acid). By using combinations of drugs this problem may be circumvented. 
Judging the effect of therapy 
If the isolated microorganism is the cause of the infection and the results of the 
susceptibility testing are correct, we usually expect a favourable response to 
therapy within 1 to 3 days. The rapidity of response is dependent on the 
causative microorganism, host defense factors, and the therapy chosen. A 
patient with normal host defense mechanisms and a pneumococcal pneumonia 
should be expected to respond to penicillin treatment within 24 to 36 hours. In 
staphylococcal septicemia or typhoid fever a clinical response to therapy takes 
much longer. The parameters to assess the results of treatment differ in each 
patient, such as the subjective state of the patient, the clinical picture, the 
temperature, the erythrocyte sedimentation rate, the white blood cell count, the 
results of x-ray examination and or other imaging procedures, and 
microbiological investigations. If the results of treatment are not in agreement 
with the expectations, a number of possible reasons should be considered, as 
listed in table 3. 
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Duration of therapy 
The duration of treatment can be determined with the parameters mentioned 
above, and based on clinical experience with similar infections. We rarely need 
guidance by advanced imaging techniques (e.g. scintigraphy, CT-scan). Over 
the last years, the recommended duration of treatment for a number of infections 
has decreased based on the results of clinical trials. 
Table 3 - Reasons for insufficient response to treatment 
1. The duration of treatment is still too short for a clinical effect. 
2. The clinical or microbiological diagnosis is wrong. 
3. Therapy is wrong: 
a. antibiotic is not active against the microorganism 
b. the infection is not reached adequately, because: 
- dosage is too low 
- oral resorption of the drug is poor 
- antibacterial concentrations at the site of infection are low 
because of: 
* poor vascularization 
* abscess or empyema 
* foreign body 
* infection at a site which is difficult too reach 
Conclusions 
The major difference between antimicrobial therapy and other therapies is that 
antimicrobial treatment has immediate implications for the commensal flora and 
the environmental flora. Every physician should be aware that, even if he 
prescribes antimicrobial drugs appropriately, he contributes to induction of 
resistance. Prudence in prescribing is essential. Finally, physicians should not 
feel "outdated" if they do not prescribe the latest antibiotics. 
The rxmárdes of аппггасгоЬіЫ therapy 27 
References 
1. Van der Meer JWM. Defects in host-defense mechanisms. In: Rubin RH, 
ed. Clinical Approach to Infection in the Compromised Host. Third ed. New York: 
Plenum Medical Book Company, 1994. 
2. Bodey GP, Ketchel S J, Rodriguez V. A randomized study of carbenicillin plus 
cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am 
J Med 1979;67:608-616. 
3. Bakker-Woudenberg IAJM, Roosendaal R. Impact of dosing regimens on the 
efficacy of antibiotics in the immunocompromised host. J Antimicrob Chemother 
1988;21:145-50. 
4. Van der Waaij D, Berhuis-de Vries JM, Lekkerkerk- van der Wees JEC. 
Colonization resistance of the digestive tract and the spread of bacteria to the 
lymphatic organs in mice. J Hyg (Camb) 1972;70:335. 
5. Vollaard EJ, Clasener HAL, Janssen AJHM, Wynne HJA. Influence of cefotaxime 
on microbial colonization resistance in healthy volunteers. JAC 1990;26:117-123. 
6. Craig WA, Vogelman В. The postantibiotic effect. Ann Intern Med 1987;106:900-
902. 
7. Mouton RP, Glerum JH, Van Loenen AC. Relationship between antibiotic 
consumption and frequence of antibiotic resistance of four pathogens - a seven year 
study. J Antimicrob Chemother 1976;2:9-19. 
8. Degener JE. Resistentie tegen antimicrobiële middelen. Proefschrift: Erasmus 
Universiteit Rotterdam, 1983. 
9. Endtz HPh, Ruijs GJ, Van Klingeren B, Jansen WH, Van der Reyden T, Mouton 
RP. Quinolone resistance in campyobacter isolated from man and poultry following 
the introduction of fluoroquinolones in veterinary medicine. JAC, 1991;27:199-208. 
10. Werkgroep Beperking Veterinair Antibiotica Arsenaal. Advies inzake inperking van 
het arsenaal van antimicrobiële geneesmiddelen voor veterinaire toepassing. 
Rijksinstituut voor Volksgezondheid en Milieuhygiene Bilthoven (RIVM), 1989. 
Rapport nr. 358471003. 
11. Quintiliani R, Nightingale CH, Crowe HM, Cooper BW, Bartlett RC, Gousse G. 
Strategic antibiotic decision-making at the formulary level. Rev Inf Dis 
1991;13(suppl 9):S770-S777. 

Quality evaluation of antimicrobial therapy 29 
CHAPTER Π 
Quality evaluation of antimicrobial therapy 
1С Gyssens, PJ van den Broek, BJ Kullberg, YA Hekster, & JWM van der Meer. 
Published in abbreviated form as: Optimizing antimicrobial therapy. A method 
for antimicrobial drug use evaluation. J Antimicr Chemother 1992; 30:724-727. 
30 
Abstract 
For the quality-of-use evaluation of antimicrobial drugs (AD), definitions and 
criteria are needed. We propose a modification of the original criteria of Kunin 
with the objective to provide maximal educational feedback of the evaluation to 
prescribers. The resulting classification allows evaluation of each parameter of 
importance associated with use of AD. In an antimicrobial drug course, 
individual prescriptions are analysed separately. Prescriptions for therapy are 
divided in empiric or documented episodes. The value of "streamlining", i.e. 
adjustment of therapy is stressed. We developed a flow chart which facilitates 
the sorting of prescriptions into categories, systematizes and accelerates the 
review. The evaluation is performed by two independent reviewers qualified in 
infectious diseases, who formulate alternative agents in case of inappropriate 
antimicrobial drug use. This is illustrated by a clinical example which obviates 
the advantages of the present classification and shows cost savings with the 
alternative policy. 
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Introduction 
The major reasons for monitoring antimicrobial drug usage are to limit the 
development and spread of resistant microorganisms and to contain costs (1). 
When we started to investigate quantity and quality of use of antimicrobial 
drugs in a prospective way in the principal services of the 911-bed University 
Hospital of Nijmegen we encountered difficulties using the existing evaluation 
categories. The most authoritative classification is the classification that Kunin et 
al developed in 1973 (table 1) (2). It has been recently adopted in its original 
form in Thailand (3). 
Table 1 - Categories of judgment of antimicrobial drug use (Kunin et al, 1973) 
I. Agree with the use of antimicrobial therapy/prophylaxis, the 
program is appropriate. 
Π. Agree with the use of antimicrobial therapy/prophylaxis, but a 
potentially fatal bacterial infection cannot be ruled out or 
prophylaxis is probably appropriate, advantages derived remain 
controversial. 
Ш. Agree with the use of antimicrobial therapy/prophylaxis, but a 
different (usually less expensive or toxic) antimicrobial is preferred. 
Г . Agree with the use of antimicrobial therapy/prophylaxis, but a 
modified dose is recommended. 
V. Disagree with the use of antimicrobial therapy/prophylaxis, 
administration is unjustified. 
Categories I and II essentially indicate "appropriate" therapy, 
categories III-IV indicate that there was some major deficiency in 
the choice or use of antibiotics by the physician managing the 
problem. 
However, over the past 17 years most authors on the subject of antimicrobial 
drug evaluation have modified those criteria to be suitable for use when 
32 
considering specific aspects of antimicrobial drug use: dosage interval (4, 5), 
loading dose (6), route (7), obtaining the necessary serum drug concentrations 
(6, 8), duration of treatment or prophylaxis (4-7, 9, 10), allergic responses (6, 7, 9, 
10), cost separated from toxicity (6, 8), broadness of spectrum (7, 10), failure to 
modify therapy after culture results become known (7), records insufficient for 
categorization (4, 5, 9). The present paper describes the development of an 
evaluation system and its advantages compared to previous classifications. 
Method 
In the quality-of-use study, each antimicrobial drug course registration form is 
completed by one researcher internist with information from the medical record 
to allow subsequent evaluation by two independent experts in infectious 
diseases. 
Criteria for evaluation and flow chart 
We adapted the criteria of Kunin et al. in order to be able to evaluate each 
parameter of importance associated with antimicrobial drug use. The modified 
criteria for evaluation are listed in table 2. Several subcategories have been 
added to the original criteria shown in table 1. 
To facilitate the selection into the numerous categories, we arranged them in a 
flow chart (figure 1). During the review, the experts use the flow chart for each 
individual prescription, so that none of the parameters is omitted. 
Definitions 
Most terms used in the evaluation categories are strictly defined, preferentially 
based on authoritative literature. We use the term "prescription" to indicate 
every time that an individual antimicrobial agent is prescribed. We use the term 
"course" to describe one episode of clinical or suspected infection or increased 
risk of infection, in which prescription(s), either consecutively or in combination, 
are written to treat or prevent this same infection (11). 
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Table 2 - Antimicrobial drug (AD) evaluation categories, present study 
I. Agree with the use of antimicrobial therapy/prophylaxis, the 
prescription is definitely appropriate. 
II. The AD prescription for therapy/prophylaxisis inappropriate due 
to : 
a. improper dosage 
b. improper dosage interval 
с improper route 
III. The AD prescription for therapy/prophylaxis is inappropriate due to: 
a. excessive length 
b. duration too short 
Г . The AD prescription for therapy/prophylaxis is inappropriate due to: 
a. more effective alternative agent (Aa): specify 
b. less toxic Aa: specify 
с less expensive Aa: specify 
d. less broad spectrum Aa: specify 
V. The AD prescription for therapy/prophylaxis is unjustified: 
use of any antimicrobial is not indicated. 
VI. Records insufficient for categorization. 
Prescriptions and courses are defined either as prophylactic or therapeutic. 
Antimicrobial therapy without clinical evidence of infection and without a 
statement in the medical record indicating a specific suspected infection is 
considered prophylaxis (7). Prescriptions for prophylaxis are labelled ADP. 
Optimal agents and modalities for prophylaxis are derived from the Medical 
Letter (12). Infections are defined using the "CDC criteria for nosocomial 
infections" (13). Prescriptions for empiric therapy (ADE) treat a presumed 
infection before culture results become available. Prescriptions for documented 
therapy (ADT) are directed to a known (cultured) pathogen, primary or after 
ADE. Continuing antimicrobial drug therapy beyond 72 hours in the presence 
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of a negative culture result or in the absence of cultures is defined as continued 
empiric therapy (ADET). To allow separate evaluation of empiric therapy and 
subsequent continuation of empiric therapy or documented therapy with the 
same drug, we split up prescriptions. After the culture results become known or 
after a maximum of 72 hours, empirically chosen drug prescriptions (ADE) are 
divided by us in continuation of empiric therapy (ADET) or documented 
therapy (ADT). Prophylactic and therapeutic prescriptions are numbered 
consecutively. 
Evaluation procedure 
For each prescription, the flow chart (figure 1) is read down from top to bottom, 
except if the records are insufficient for categorization (stop at category VI) or if 
the criteria for infection (13) are not met (stop at category V, unjustified). 
Intravenous prophylaxis begun too early (not within 2 hours of induction of 
anaesthesia) or prophylaxis begun postoperatively is considered useless, thus 
equally classified as unjustified (category V). 
Antimicrobial drug prescriptions can be inappropriate for several reasons at the 
same time and therefore can be placed in more than one category or 
subcategory (categories IV down to II). Prescriptions for therapy are considered 
inappropriate if errors are made in dose (category IIa), interval (category lib) or 
route (category lie), violating established pharmacokinetic principles (14). As 
correct length of therapy is frequently arbitrarily established, a duration of 
treatment which largely differs from the duration which is proposed in a leading 
infectious diseases textbook (15) is considered either too long (category Ilia) or 
too short (category Illb). The reviewers are asked to give an alternative agent 
(Aa) for reasons of optimal effectiveness (microbiological and pharmacodynamic 
grounds) (category IVa), less toxicity (category IVb), and less cost (category 
Г с) in case of equieffectivity (14, 15) of the antimicrobial drug. The strategy of 
"streamlining" is adopted, in which empirically given, multiple-drag, broad 
spectrum antimicrobial therapy is progressively replaced by narrow spectrum 
therapy as soon as possible after the culture results become known (16). This 
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Figure 1 - Flow chart for quality-of-use evaluation of antimicrobial drug 
prescriptions. 
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often results in single drug therapy and cost containment. If there is an 
equieffective alternative drug which has a narrower spectrum, it is formulated 
(category IVd). 
Cost calculation 
After the reviewing process, cost comparison is made between the global cost of 
the given treatment and the global cost of the alternative regimen proposed by 
the reviewers. The method of global cost calculation which includes purchase 
costs, administration and monitoring costs is described elsewhere (17). 
Data processing 
The resulting categories of the evaluation are entered into a computer 
spreadsheet and database program. 
Example 
A clinical example is summarized in table 3. A 74-year-old man with diabetes 
mellitus is admitted with the clinical signs of septicaemia. His weight is 55 kg 
and serum creatinine is 120 mmol/1 (estimated creatinine clearance 40 ml/min). 
Ceftazidime 1 g tid iv and gentamicin 80 mg tid iv are prescribed on August 
7,1990 at 8 pm. Blood cultures are drawn before treatment. The suspected site of 
entry, a venous ulcer on his lower leg yielded Pseudomonas aeruginosa, 
sensitive to ceftazidime and gentamicin, 2 days earlier. On August 9 all 4 blood 
culture bottles grow Gram-positive cocci in clusters. The culture from the wound 
remains sterile. Gentamicin is withdrawn and vancomycin, 500 mg bid is added 
to the regimen. On August 10, the laboratory reports the growth of 
Staphylococcus aureus, sensitive to methicillin and resistant to penicillin, from 
the blood. The patient's condition is improving. Ceftazidime and vancomycin are 
continued until August, 12, when the attending physician stops the ceftazidime. 
Vancomycin is changed to flucloxacillin, 1 g qid when the microbiologist visits 
the ward on August, 13. Flucloxacillin is stopped on August, 16. By use of the 
flow chart, the reviewers made a classification into categories (table 3). 
The empiric choice of ceftazidime (ADE1) was considered definitively 
appropriate in view of the previous cultures (category I); no alternative drug 
was proposed. Combination therapy with gentamicin (ADE2) was considered 
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appropriate by reviewer 1. However, due to the impaired renal clearance the 
dose interval was considered too short (category lib). Monotherapy with 
ceftazidime seemed sufficient to reviewer 2 (category V). The withdrawal of 
gentamicin and the addition of vancomycin (ADE3) was considered an 
acceptable change in view of the culture results. The dose reduction was this 
time according to the patient's renal function and reviewer 1 considered the 
prescription as definitely appropriate (category I). However, the other reviewer 
would have given flucloxacillin, because methicillin resistant S. aureus (MRSA) 
was considered unlikely on epidemiological grounds in this hospital (incidence 
MRSA <1%), and Staphylococcus epidermidis was not thought to be the 
causative organism on clinical grounds. Compared to vancomycin, flucloxacillin 
is a less toxic, less expensive and less broad spectrum drug and therefore ADE3 
was labelled as category IVb,c,d. To continue ceftazidime (ADT1) for 
documented staphylococcal bacteraemia after August 10 was considered 
unjustified (category V). The continuation of vancomycin (ADT2) was then 
judged by both reviewers as category IVb.c.d: the causative organism was at 
that time known to be sensitive to flucloxacillin. The change to flucloxacillin 
(ADT3) on August 13 was right, but the duration of treatment (10 days) was 
considered too short for S. aureus septicaemia (category IHb). The global cost 
of the illustrative course, i.e. the sum of empiric and documented therapy (ADE 
and ADT prescriptions), was Dfl. 1 954 (£ 576) (table 3, left cost column). The 
cost of the proposed treatment with alternative agents (Aa) formulated by 
reviewer 1 was Dfl 1742 (£ 514) (table 3, right cost column). Although the 
proposed duration of treatment was longer, savings of at least Dfl 212 or £ 62 
(11%) were predicted for the alternative policy in this case. 
Discussion 
Using the original classification of Kunin (table 1), the illustrative case would 
have been difficult to classify. Our modified classification system allows separate 
evaluation of each individual drug according to well documented parameters of 
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antimicrobial therapy, whereas the original classification allocated courses in one 
of five broad categories, relying on the absolute authority of the infectious 
diseases specialist. Because opinions of experts may be different, we prefer 
review by two such specialists. The system visualizes well where the experts 
disagree, as illustrated in the clinical example. Credibility is increased by clearly 
defining terms, relying on authoritative literature (18). Many previous 
classifications consider courses instead of prescriptions and therefore do 
unjustice to prescribers: in a combination course, one prescription can be correct, 
the other a poor choice; the whole course is then considered inappropriate (2, 5, 
7, 9). The value of streamlining antimicrobial drug therapy as an important tool 
in limiting the unnessecary use of broad spectrum antimicrobial drugs and in 
cost containment (7, 19) is stressed in our evaluation procedure. The drug may 
be well chosen as an empiric start, but the remainder of the treatment may be 
unjustified or the spectrum too broad after culture results are known (7). This 
problem of judgment is solved by dividing the prescription in empiric and 
documented therapy episodes. This technique artificially increases the total 
number of prescriptions, so total number of prescriptions should not be used for 
quantitative analysis of the review. 
For prescriptions judged inappropriate, all alternative drug regimens can be fully 
formulated, thus constituting a comprehensible example of the alternative 
antibiotic policy for clinicians with their own patient material. Predicted savings 
can be calculated. Like most authors who have tried to deepen the classification 
of Kunin we had to add supplementary categories and/or subcategories. Some 
aspects of antimicrobial therapy categorized by others as described in the 
introduction were not included in new categories. "Allergic responses" is 
included in category IV b (less toxic alternative agent). "Loading dose" and 
"obtaining the necessary serum drug concentrations" are only required for a few 
antimicrobial drugs. We analysed those aspects separately in order to reduce the 
length of the category list. With the help of computer spreadsheet programs the 
the processing of numerous data is not a major problem. However, long lists of 
categories are difficult to handle during the review. Our flow chart systematizes 
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and accelerates the reviewing process. We conclude that the present 
modification of Kunin's criteria allows maximal educational feedback of the 
evaluation to prescribers. 
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Abstract 
In the actual Dutch hospital budget system, inpatients' drug costs generate no 
revenue. Efforts to diminish drug costs result in financial benefit for the 
institution. This is also the case for antimicrobial drugs. To maximize cost 
containment, efforts are to be directed to all cost components : costs of 
acquisition, preparation and administration and monitoring of antimicrobial 
drugs. We describe the method of cost-identification analysis which was 
performed in our hospital during a review of antimicrobial drug usage 
evaluation. Purchase contract prices for antimicrobial drugs vary between 
hospitals and they are invariably lower than wholesale prices. However, to allow 
generalization of our calculation results to other Dutch general hospitals, we 
chose wholesale purchase prices of antimicrobial drugs and national prices for 
salaries and hospital costs. Global cost comparison points out the most cost-
effective system of intravenous administration. Push injection is the most 
economic way to administer i.v. drugs which do not require dilution or 
prolonged infusion time. For stable solutions, such as metronidazole, ready-to-
infuse bags are the most economic system. The global cost calculation is listed 
for commonly used antimicrobial drugs for inpatients. A cost comparison is 
given for vancomycin CP and teicoplanin, two antistaphylococcal drugs which 
are probably equieffective. The result of global cost comparison contributes to 
the decision to include new drugs in the hospital formulary or to replace older 
ones. 
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Introduction 
The trae cost of health care is what health care consumes of society's resources. 
Under a traditional medical system, hospital costs (i.e. consumption of hospital 
services such as those provided by the pharmacy and laboratory) are passed to 
the patient or third-party payers and generate revenues for the hospital, 
contributing to the inflationary spiral in health care costs. In general hospitals in 
the Netherlands, the current budget system was introduced in 1983 and 
university hospitals followed in 1984. These budgets are based on the hospital's 
consumption of resources during the year 1982 for general hospitals and 1983 
for university hospitals. In this budget system, it becomes of primary importance 
to contain internal costs since the Government has limited hospital costs in an 
external budget. In 1988, a function-directed budget system was introduced for 
general hospitals (1). A significant portion of the total operating hospital budget 
is drug purchases. As in the prospective payment system which is used in the 
U.S. (i.e. reimbursment categorized according to Diagnosis-Related-Groups), 
drug costs for inpatients generate no revenues. Antimicrobial drugs account for 
the largest proportion of all drugs, ranging from 13 to 37% of these purchases 
by hospitals in a European study (2). However, the true cost of antimicrobial 
therapy for the institution involves considerably more than the purchase cost of 
the drug employed (3). The recognition that some drugs which are very 
inexpensive to purchase, are expensive to use, prompted the development of 
methods to estimate the global cost of antimicrobial chemotherapy (4-6). We 
performed a cost-identification analysis as described by Eisenberg (7), during a 
review of antimicrobial drug usage evaluation. We applied a method of global 
cost calculation which takes into account acquisition costs, administration and 
preparation costs, and monitoring costs in our hospital (8). We subsequently 
constructed a cost calculation system which quantifies the cost difference for 
each route and each intravenous system of antimicrobial drug administration. 
The method permits comparison of the cost of actual and alternative 
antimicrobial drug policies in the quality-of-use review. 
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Method 
During a review of antimicrobial drag use evaluation in the 948-bed University 
Hospital of Nijmegen, cost parameters were determined for the following 
components of antimicrobial chemotherapy of inpatients: antimicrobial drug 
purchase costs, clerical costs, costs to prepare and administer the drugs and costs 
to monitor the drugs. The different cost components were arranged in a 
spreadsheet which permits calculation of the global cost per dose. 
1. Purchase costs 
The official wholesale price-list "Groothandelsprijslijst Courant Brocacef 1990" 
was chosen for acquisition cost of antimicrobial drugs, instead of contract prices 
of the hospital. Contract prices tend to vary between hospitals, reflecting the 
institution's antibiotic and purchase policy. The true acquisition costs of 
antimicrobial drugs in hospitals are generally below the wholesale price. 
However, the invoice prices of drugs include additional 6% taxes. 
2. Clerìcal costs 
Antimicrobial drugs listed in the hospital formulary are kept in stock in the 
wards. For formulary drugs, clerical costs per dose were determined by the 
labour time of nurses filling out the patient's medication sheet. In case of 
nonformulary drugs, extra time was needed to obtain individual receipts from 
the treating physician. 
3. Costs to prepare and administer drugs 
Only the time of nurses was taken into account, since pharmacists were not 
involved in the preparation of admixtures for injection, and formulary drugs 
were kept in stock in the wards. 
Oral administration, i.v. push (bolus) injection, i.v. piggyback (quick, small-
volume infusion) and intermittent i.v. infusion (large volumes up to 500 ml, 
requiring 30 minutes or more) were studied for cost comparison. Intramuscular 
injections were rarely used for antimicrobial drug administration in hospitalized 
patients. Most i.v. antimicrobial drugs had to be reconstituted with sterile water 
from powder vials as for cephalosporins and penicillins. Some manufacturers 
provide dilution fluid as for teicoplanin. 
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Ampoules contain a high concentration of antibiotic solution as for gentamicin 
marketed as Garamycine®. Reconstituted vials were either injected with the 
help of a 20 ml syringe (push) into the tubing, were injected in a piggyback, or 
were injected into a large volume infusion bag for intermittent infusion when 
dilution was required, as for clindamycin marketed as Dalacin®. The direct costs 
associated with antimicrobial drug administration were broken down into 
personnel time and supplies. A questionnaire was given to the senior nurses of 2 
different wards. They were asked to collect several (minimum three) time 
measurements from their staff for all the components of oral and i.v. antimicrobial 
drug administration. The nurses noted the time required with the help of a 
wristwatch. Subsequently, the senior nurses were interviewed. Surveillance time 
of the i.v. intermittent infusions was estimated for various duration of infusions 
(30, 60, 120 and 240 minutes). Both measurements and experience data were 
used to deduct mean administration time. Personnel time was multiplied by the 
average hourly salary rate of nurses to determine personnel costs. 
System supply costs were also obtained from a wholesale price-list. Similarly, 
contract prices of supplies are usually lower as large quantities are purchased. 
Additional 18.5 % taxes are added in the invoice. Costs of personnel time and 
supplies were arranged in a separate spreadsheet to allow calculation of the 
administration costs per dose for each system of administration. 
4. Monitoring costs 
When an antimicrobial drug has a narrow therapy vs. toxicity range, additional 
laboratory tests are required to monitor drug concentrations in blood and organ 
function. For calculation of the monitoring costs of aminoglycosides, we 
assumed that no extra laboratory tests were required during the first 72 hours of 
treatment in patients with normal renal function in the absence of hemodynamic 
instability (9). However, patients presenting with unstable circulation due to 
Gram-negative septicemia, patients with burns, or patients who had impaired 
renal function required two extra measurements of creatinine and one set of 
aminoglycoside serum concentrations (peak and trough) per week for 
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monitoring. If treatment continued beyond 72 hours, even in patients with 
normal renal function, similar extra laboratory tests were needed. Since the real 
costs of laboratory tests are unknown on a national level, laboratory cost 
calculations were based on cost approximation by the Spaander points system. 
This system takes into account total laboratory operating costs (laboratory staff 
wages, supplies, equipment, energy etc). Each laboratory test is given a number 
of Spaander points which reflects the relative contribution of the test on 
workload and consumption of supplies. The total annual production by a 
laboratory is expressed in an amount of Spaander points. Dividing the total 
production by total operating costs results in a cost per Spaander point, which 
varies per laboratory. However, to allow cost comparison of laboratory tests on 
a national level, the average national cost per Spaander point, based on national 
guidelines was used for calculations (Centraal Orgaan Tarieven Gezondheids-
zorg, Richtlijnen Wijziging Declaratie Structuur 1988) (10). 
Results 
1. Purchase costs 
The acquisition costs (wholesale price) per dose for commonly used 
antimicrobial drugs are listed in table 1, column 5. 
2. Clerical costs 
Nursing clerical time per dose was considered a question of seconds for 
formulary drugs, and not taken into account. However, nonformulary 
drugs took more time, i.e. an average of 0.5 min per dose. 
3. Costs to prepare and administer drugs 
The results of the nurse's average time needed to reconstitute, prepare and 
administer formulary drugs are shown in table 2. Oral doses (tablets or capsules) 
required 1 minute. Total time for i.v. push injections ranged from 4.5 minutes to 
8.5 minutes, depending on the complexity of reconstitution. Reconstitution 
times varied from 1.5 to 4 minutes. For ease of calculations, we allocated the 
antimicrobial drugs to two groups: normal reconstitution (mean 2 min) and 
difficult reconstitution (mean 4 min). The average time required for injection into 
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Table 2 - Nurse's time needed for reconstitution, preparation and administration of one 
























































* Infusion time in parentheses; 1 min surveillance time per 15 min infusion time up to 
60 min, then 1 min surveillance time per 30 min infusion time 
tubing (push) was 4.5 minutes. Suspending an infusion bag and connecting it to 
the patient's i.v. device (i.v. infusion tubing or heparin-lock catheter), averaged 
2 minutes. All antimicrobial drug infusions were regulated with the help of a 
Table 3 - Costs of intravenous supplies per dose (Dfl) 
Supplies 
Syringe 5 ml 




Method of administration 










































•Reconstitution fluid needed. 
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roller clamp. Total infusion times were according to the package insert. For 
surveillance of the infusion, one minute extra time was needed for 15 minutes 
infusion time, up to a total of 4 minutes for one hour infusion time. Intravenous 
antimicrobials which took 2 hours infusion time (vancomycin CP 1 g) and 4-6 
hours infusion time (amphotericin B) scored 2 minutes/hour extra. The 
calculated cost of a nurse's minute was Dfl 0.60 in 1990, based upon factual 
nursing costs of this hospital. The supplies and associated cost (disinfection) 
needed for all procedures are listed in table 3. 
As an illustrative example, the comparison between the costs to prepare and 
administer teicoplanin and vancomycin CP is shown in table 4. For teicoplanin 
and vancomycin CP, the exact measurements for preparation and administration 
time are used. Reconstitution of a single vial required 3 minutes for both drugs. 
Since teicoplanin was manufactured in vials of 200 mg, for the reconstitution of 
teicoplanin 400 mg, 6 minutes were needed. For injection of teicoplanin, 7.5 
minutes were needed, due to the production of foam when nurses automatically 
shook the vial during the reconstitution process. 
Since teicoplanin was manufactured in vials of 200 mg, for the reconstitution of 
teicoplanin 400 mg, 6 minutes were needed. For injection of teicoplanin, 7.5 
minutes were needed, due to the production of foam when nurses automatically 
shaked the vial during the reconstitution process. 































* The cost of a nurse's minute is Dfl 0.60 
4. Monitoring costs 
Laboratory costs are listed in table 4. Monitoring aminoglycosides, as for 
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gentamicin, raised the weekly treatment costs by Dfl 88.40. This amount was 
due to serum creatinine measurement Dfl 6.80 twice weekly + one 
aminoglycoside serum peak and trough concentration Dfl 74.80. In a dosing 
schedule of gentamicin twice daily the additional monitoring cost/dose was Dfl 
6.30. Similar monitoring of vancomycin CP amounted to Dfl 144 per week. 
When audiometry was performed, as advised in case of prolonged administration 
by the package insert, the weekly costs were Dfl 174 or Dfl 12.40 per dose 
(twice daily dosing). The package insert of teicoplanin advises to control renal 
and auditory function in patients with renal function impairment or prolonged 
administration, without measurement of serum concentrations. These costs 
amounted to Dfl 44 per week or Dfl 6 per dose. Serum (trough) concentrations 
were only considered meaningful for monitoring efficacy. The cost of a serum 
concentration of teicoplanin was Dfl 65.45. Laboratory costs per dose for 
vancomycin and teicoplanin are listed in table 6. 
Table 5 - Costs of laboratory tests for antimicrobial drug monitoring in Dfl 
Test Spaander points * Cost 
leukocytes 2 2.72 
creatinine 5 6.80 
potassium 5 6.80 
ASAT 8 10.88 
serum concentration 
gentamicin 20 37.40 
vancomycin 35 65.45 
* Spaander point of the chemistry laboratory = 1.36 Dfl 
Spaander point of the bacteriology laboratory = 1.87 Dfl 
5. Global costs 
The resulting global costs of common antimicrobial drugs are listed in table 1 (A 
complete list can be obtained from the authors upon request). As an illustrative 
example, global cost comparison between a formulary antimicrobial drugs 
(vancomycin CP) and a newly marketed antimicrobial drug with similar efficacy 
Global cost calculation S3 
(teicoplanin) is shown in table 6. For teicoplanin, at least one loading dose is 
needed to rapidly achieve steady state concentrations (11). For the first week of 
treatment with teicoplanin, the costs per week are the result of eight doses. 
Table 6 - Cost comparison of vancomycin CP and teicoplanin (Dfl) 
Generic name Dosing Routef Wholesale Adminisration Monitoring Global Global 
(Brand) schedule i.v. cost/dose cost/dose cost/dose cost/dose cost/week 
(mg) 
Teicoplanin 400/24 h* 
(Targocid) 
400/24 h 



























*First week; including 1 loading dose, prolonged administration 
t i.V.: intravenous 
Discussion 
In this paper we describe a cost-identification analysis of hospital antimicrobial 
drug therapy. The computer spreadsheet technique permits quick calculation if 
values of the cost components change, as for purchase prices or nurse's wages. 
Since purchase contracts differ between hospitals due to competitive bidding or 
quantity of drug purchased, wholesale prices were preferred to allow objective 
comparison between drugs on a national level. The contract acquisition price of 
an antimicrobial drug which is commonly used in an institution can be as low as 
25% of its official wholesale price. However, this situation is rather exceptional, 
and it only exists for a few older drugs. The acquisition cost of most 
antimicrobial drugs is about 10% lower than the official price, after taxes are 
included. 
We did not take into account pharmacy handling costs. Pharmacy distribution 
costs vary with the logistical organization of drug distribution within the 
hospital. Steenhoek combined pharmacy and nurse handling costs in his cost 
comparison of antibiotic therapies (1). 
The present cost calculation points out the most economic way and system to 
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administer i.v. antimicrobial drugs. Different cost components seem relatively 
important for different drugs. The administration costs of benzylpenicillin 1 MU 
i.v. represent 83% to 88% of the global cost per dose and i.v. push injection is 
30% less expensive than i.v. piggyback infusion (table 1). When the 
predominant cost element is the acquisition cost of the drug (vancomycin CP, 
teicoplanin), the proportional savings by changes in system of administration 
(i.v. push or intermittent infusion) and dosing schedule seem negligible (table 6). 
However, administration costs of i.v. piggyback (generally Dfl 8.80) are almost 
always larger than those of i.v. push injection (generally Dfl 5.80), as shown for 
benzylpenicillin and cefazolin in table 1. The infusion bag (50 to 500 ml) 
accounts for most of the cost difference between both systems. Thus, push 
injection invariably saves a fixed amount of money per dose of drug which does 
not require dilution or prolonged infusion. Although in some Dutch hospitals 
nurses are not authorized to perform injections into i.v. tubing or i.v. catheters, 
the reports of the committee on responsibility of nurses in general hospitals 
(VAR) advise the same code of authorization for the medical acts of intravenous 
infusion and intravenous injection (12, 13). Moreover, push injection has 
increased security since rapidly occuring side effects are noted faster. Thus, both 
for safety reasons as well as from a cost containment point of view, i.v. push 
injection (3-5 min) is preferable to short term (< 15 min) piggyback infusion. 
Intermittent infusion ( large volumes, requiring more than 20 min) should be 
reserved for drugs that require dilution or a prolonged infusion time such as 
vancomycin or amphotericin B. For stable solutions, ready-to-infuse bags are the 
most economic system for intermittent administration (metronidazole, table 1). 
The concept of continuous (24 h) i.v. infusion, based on pharmacodynamic 
properties of some antimicrobial drugs, is not discussed here. 
Teicoplanin has the advantage over vancomycin CP that it can be administered 
by push injection. However, by inadvertence, the production of foam during 
reconstitution can add several minutes to the subsequent injection and savings 
are less than one would expect (table 4). 
Another strategy of antimicrobial drug administration which can save time of 
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nurses and supplies is illustrated in surgical prophylaxis. All anaesthesiologists in 
our hospital preferred to administer cefazolin by push injection (see Chapter VI). 
On the other hand, nurses in surgical wards almost invariably administered 
cefazolin in piggyback. The cost of one dose of cefazolin for peri-operative 
prophylaxis given by the anaesthesiologist in the operating theatre is Dfl 17. 
The same dose administered preoperatively on the ward by a nurse amounts to 
Dfl 23. Both calculations are shown in table 1. 
The cost of aminoglycosides rises by Dfl 6.30 per dose (twice daily dosing) after 
72 hours when monitoring becomes necessary. Aminoglycosides are much less 
expensive when used in empiric therapy for synergy and broadening of the 
spectrum during the first days before culture results become known. Monitoring 
costs can be avoided by replacing empirically given aminoglycosides by less 
toxic antimicrobial drugs in subsequent documented therapy. 
From table 1 it is clear that single-dose prophylaxis with a combination of 
antimicrobial drugs is not always more expensive than prophylaxis with one 
drug; for example, peri-operative prophylaxis with one dose of piperacillin (Dfl 
52) is more than twice as expensive as the combination of cefazolin with 
metronidazole (Dfl 23). 
The global cost per day (table 1) or per week (table 6) should be considered for 
cost comparison between drugs, as the daily cost of antimicrobial therapy can be 
largely influenced by differences in dosing schedules and monitoring. 
We did not include complication costs in our calculation system. To our 
knowledge, there are no European data on the subject. Figures from the United 
States are irrelevant for the European situation because they are largely 
influenced by litigation costs. Still, we feel that for antimicrobial drugs with 
established renal and otovestibular toxicity, such as aminoglycosides, a certain 
amount of money has to be added to obtain the true global cost of these drugs. 
This is a reason to try and replace toxic antimicrobial drugs from the formulary 
by less toxic, equieffective ones. Global cost considerations should guide 
decisions to introduce new drugs for the hospital formulary rather than purchase 
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costs of antimicrobial drugs. 
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CHAPTER IV 
Antimicrobial prophylaxis and therapy in surgery, gynaecology 
and orthopaedics. 
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Abstract 
Following a one-month prospective study of all antimicrobial drug use in 
surgical departments, new guidelines were implemented. The review was 
repeated after 2 years. Total number of patients (766 vs 744) and operations 
(542 vs 522) were similar. In both study periods, one third of the patients were 
prescribed antimicrobial drugs. Prophylactic drug consumption decreased from 
0.75 to 0.53 DDD/operation. Compliance with guidelines improved from 32% to 
79%. Duration of prophylaxis > 24 hours decreased from 21% to 8%. Single 
dose prophylaxis increased from 34% to 80%. Quality of the prophylactic 
courses improved, as evaluated by experts using established criteria. For 
prophylaxis, cost savings amounted to 57%. Better quality of therapeutic 
courses was associated with a cost increase of 15%. Indicators of satisfactory 
outcome with the new policy were a stable median length of stay (5.5 days in 
the first review and 5.0 days after intervention) and a reduction in the number of 
nosocomial infections/100 bed days treated with antimicrobial drugs (1.0 before 
intervention vs 0.77 after intervention). 
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Introduction 
Antimicrobial drugs account for 13 to 37 % of the drug budget in European 
hospitals (1); between 30 and 60% of the courses are for prophylactic use (2, 3). 
The main reasons for monitoring antimicrobial drug use are to optimize medical 
care, to limit and reduce the spread of resistant microorganisms and to contain 
costs. In the U.S., the pressure to contain costs imposed by diagnosis-related 
group (DRG) prospective reimbursement has greatly influenced antimicrobial 
drug control (4). In Europe, the pressure to reduce costs is still increasing in 
countries with budgeting systems such as in the Netherlands. Parallel to a 
concern about increasing costs of antimicrobial drugs, many authors have 
described inappropriate use (5, 6). Surgical prophylaxis with antimicrobial drugs 
is long recognised as an area where overuse is often found and where it is also 
the easiest to correct (7, 8). Many antimicrobial drug intervention strategies are 
described to optimize quality at lower cost, including education, the 
development of protocols, targeting on specific drugs (9). A number of criteria 
for optimal therapy and prophylaxis are well established (10, 11). A widely 
accepted regimen of preoperative prophylaxis is 1 g of the first generation 
cephalosporin cefazolin, given within an optimal period of 30 min before 
incision, and repeated if the operation lasts for more than 3 h (12, 13). We 
conducted a prospective intervention study in three surgical departments in a 
large university hospital : 1) to define antimicrobial drug use (prophylaxis and 
therapy) in terms of quality and costs 2) to measure the effect of interventions to 
improve the quality of antimicrobial drug courses. 
Patients and Methods 
Setting 
The University Hospital Nijmegen is a 948-bed teaching hospital with 344 
surgical beds, and + 1600 operations/month on inpatients. The study took place 
in the departments of gynaecology and obstetrics, surgery, and orthopaedics, 
hereafter named G, S and O. The hospital formulary listed 20 parenteral and 26 
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oral antimicrobial drugs at the start of the study. In the previous year, 
antimicrobial drugs accounted for 22% of the hospital drug budget of Dfl 14 
million ($ 8.1 million). The Antibiotics Committee had issued a new edition of an 
antimicrobial drug formulary with guidelines for surgical prophylaxis and 
therapy. In addition, some departments had their own treatment protocols which 
contained detailed guidelines for antimicrobial use by staff and residents. We 
will refer to both as "guidelines". A classification of surgical procedures was 
used based on the original classification of Cruse and Foord adapted with newer 
guidelines (12, 14). Length of stay was calculated as follows: number of in-
hospital days of patients included in the study/ number of patients included in 
the study. 
Antimicrobial Drug Use Review 
The first review took place during separate one-month study periods in 1990. 
Antimicrobial drug consumption was prospectively reviewed in 766 
consecutive surgical patients. After a period of intervention, a similar review of 
744 consecutive patients was repeated in 1992. The quality-of-use studies were 
performed by an infectious diseases physician and junior clinical pharmacists, 
who visited the wards and collected data on all patients receiving antimicrobial 
drugs on a daily basis. Abstracts were made of each antimicrobial drug course. A 
course was defined as an episode of clinical or suspected infection or increased 
risk of infection, in which prescription(s), either consecutively or in combination, 
were written to treat or prevent this particular infection. Clinical information was 
retrieved from the patient's record. Infections were defined according to CDC 
definitions for nosocomial infections (15). Nosocomial infection was defined as 
active infection that was not present or incubating at the time of admission. 
Microbiology results were obtained directly from the laboratory of medical 
microbiology. The schedule of systemic antimicrobial drug was copied from the 
patient's medication chart (Kardex®) and from the anaesthesia record. 
Antimicrobial drug use was converted in Defined Daily Doses (DDD). The 
Defined Daily Dose (DDD) represents the average therapeutical dose for an 
adult for the standard indication (16). Quantitative use in DDD of a drug/100 
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bed days can give an indication of the number of patients treated with the drug 
(17). Quantitative use was analysed by comparing the number of courses in the 
population at risk in the study periods (courses/100 bed days, incidence rate) 
and by comparing DDD/100 bed days. The DDD /100 bed days has been chosen 
by the WHO Drug Utilization Research Group as a unit of comparison between 
hospitals. Direct and indirect costs were calculated in Dutch guilders (1 Dfl= 
0.65 $) by a method for global drug cost calculation, which includes costs of 
drug administration and costs of monitoring (18). Qualitative use was analysed 
in two ways. First, compliance with existing hospital guidelines was checked at 
the time of the initial review, and compliance with the department's new 
protocol after the intervention. Second, two independent experts in infectious 
diseases (named reviewer 1 and reviewer 2) evaluated quality in the following 
way: prescriptions were assessed using 6 categories of good antimicrobial use 
by means of established criteria arranged in a flow chart. The method is based on 
the original criteria of Kunin (10) and is described previously (11). In short, 
prescriptions can be definitely appropriate (category I), unjustified (category V) 
or the records insufficient for categorization (category VI). The other 
prescriptions are placed in categories of inappropriate use II, III, and IV. 
Inappropriate prescriptions can be allocated to several categories at the same 
time: incorrect dose (IIa), interval (lib) or route ( lie), duration too long (Ilia) or 
too short (Illb). If relevant, the experts cite a better alternative agent due to 
higher efficacy (IVa), lower toxicity (category IVb), lower cost (category IVc) 
and less broad spectrum (IVd). Global costs of actual and alternative policies (in 
this study the alternative policy proposed by reviewer 1) are compared to 
project savings by changes in policy. 
Intervention 
After the first review, a report of each department was sent to their chiefs of 
staff. The report was accompanied by recommendations for the alternative 
antibiotic policy of reviewer 1, a policy in concordance with the hospital's 
antimicrobial drug policy. The principal goal was to introduce a universal 
surgical prophylaxis standard of single-dose cefazolin at incision (with 
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metronidazole where an anaerobic spectrum was needed). The report and 
recommendations were discussed by the surgical staff. The recommendations 
were adapted to new protocols for prophylaxis and therapy with the help of a 
surgical staff member. After approval by the Antibiotic Committee, a 
presentation of the report and the protocol was held in the departments, in part 
by the surgical staff member. In most departments, the first dose of surgical 
antimicrobial prophylaxis was given by the anaesthetist in the operating room. 
Because anaesthesias were performed by a rotating pool of 40 anaesthetists 
(staff members and residents), the department of anaesthesiology was 
interviewed by means of a questionnaire. The inquiry showed deficient 
communication between anaesthetists and surgeons on the subject of 
administration and timing of prophylaxis (see chapter VI). In the intervention 
period, the results of the inquiry were used in an educational setting. The 
implementation of the protocols was assisted by the department of clinical 
pharmacy. Junior pharmacists organized briefings for nurses in the operating 
departments and in the wards, and the standardized prophylaxis guidelines were 
visualized in the wards and the operating rooms. Operating room drug stocks 
were reorganized. In departments S and O, pharmacy technicians discussed 
protocol violations with prescribers and nurses on their twice weekly visits to 
the wards, as a long term surveillance. 
Generally, χ2 tests were applied to establish systematic differences. The 
Wilcoxon's test was used for the comparison of length of hospital stay. The 
Fisher's exact test was used to compare duration of prophylaxis. Agreement 
between the experts was assessed by к coefficients. 
Results 
Quantitative use 
Table 1 shows the demographic characteristics of the study populations in the 
first and second study period for the three departments. The number of patients 
hospitalized, mean age, and the number of operations performed in the study 
months was similar in both reviews. The proportion of patients with 
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antimicrobial drags was also similar. The median length of hospital stay in both 
study periods was not statistically different in departments G and S. In 
department O, the median length of stay had decreased significantly (p=0.005). 
The distribution of the type of operations was also similar in the two study 
periods. 
Quantitative consumption data before and after the intervention are presented 
in table 2. The proportion of parenteral DDDs increased in all departments. The 
shift from oral to parenteral route was most striking in department O. 
Quantitative data were analysed in detail according to prophylaxis and therapy. 
Prophylaxis 
Slightly more operations were performed under antimicrobial prophylaxis in the 
second review (table 2). However, the consumption of prophylactic 
antimicrobial drugs expressed in DDD/operation decreased. After the 
intervention, only 16% of total consumption (in DDDs) was for prophylactic use, 
compared with 31% in the first review. In the first review, a variety of 
antimicrobial drugs were used for prophylaxis in 24h-regimens (figure 1). An 
oral regimen that combined neomycin and bacitracin (Nebacetine forteR) was 
used for large bowel surgery in department S and cefalexin was mainly 
prescribed in department G. Furthermore, when the medication order on the 
anaesthesia record mentioned "24 h", some nurses in the wards did not take into 
account the dose given by the anaesthetist in the operating room. This practice 
resulted in an extra dose in half of the 24h- prophylactic prescriptions in 
department S and in 10% of the 24h-prophylactic prescriptions in department O. 
After the intervention, the variety of regimens was mostly replaced by single 
dose cefazolin (plus metronidazole). Amoxicillin plus gentamicin was used for 
the prophylaxis of endocarditis (figure 1). 
Therapy 
Slightly less patients were treated therapeutically in the second review period 
(table 1). Also, therapeutic courses/100 beddays slightly decreased (table 2). 
Abdominal and pelvic infections were the most frequent type of infections 
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treated with antibiotics in both reviews, 37% and 40% respectively. Urinary 
tract infections accounted for 23% and 24% respectively. The number of 
nosocomial infections treated with antimicrobial drugs/100 bed days was 1.0 
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Figure 1 - Consumption of antimicrobial drugs for surgical prophylaxis in three 
departments of a university hospital before and after an intervention, one-month 
reviews. 
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In all departments, therapeutic consumption (expressed in therapeutic DDD/100 
bed days) increased due to an increase of DDD/therapeutic course (table 2). 
Two reasons could be found for the increase: first, the new protocols advised to 
treat severe infections such as osteomyelitis with higher doses and for longer 
periods than usual; second, narrow spectrum penicillins (penicillin G, 
flucloxacillin) were preferred in directed therapy. For the treatment of 
osteomyelitis with benzylpenicillin 6 million units daily, the prescribed daily 
dose was 3 times the DDD (PDD/DDD ratio =3). 
The major changes in the types of therapeutic antimicrobial drags are presented 
in table 3. Penicillin use increased fourfold and i.v. cephalosporins increased by 
half. Part of the changes in drug use were not foreseen. Amoxicillin-clavulanate 
had been introduced in the hospital formulary in december 1990. The new 
treatment protocol advised use of the drag only for the treatment of postpartum 
endometritis. In the second review, amoxicillin-clavulanate consumption 
amounted to 6.9 DDD/100 bed days in department G, which represented 86% of 
its penicillin use, and 39% of the departments' total therapeutic use (table 3). 
Amoxicillin-clavulanate was not mentioned in the new protocols of departments 
S and O. In those departments, amoxicillin-clavulanate consumption remained 
low, 4% and 8% respectively. Ciprofloxacin, added to the formulary in 
september 1991, but not introduced in the treatment protocols, was not or still 
minimally used in the three departments during the second review. 
Costs. 
Cost figures (in Dfl) are presented in table 4. Overall, cost savings amounted to 
11%. Projected annual savings for the three departments amounted to Dfl 
49,800. 
Prophylaxis 
Figure 2 presents the total distribution of costs of prophylaxis by antimicrobial 
drug group before and after the intervention in the three departments. 
Piperacillin was only used in department G. Before the intervention, piperacillin, 
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costs. In department S, clindamycin, that accounted for 16% of total 
consumption, accounted for 48% of costs. Potential savings in prophylaxis, 
calculated by the experts after the first review, were estimated at 83%. The 
savings realized in the second review amounted to 57% (table 4). Prophylactic 
cost/operation was halved. Savings were merely realized by replacing the broad 
spectrum agent piperacillin (Dfl 44.9/single dose) and the regimen of gentamicin 
with clindamycin (Dfl 107.6/24h course) by cefazolin (Dfl 6.3/single dose) with 
or without metronidazole (Dfl 6.1/single dose). 
Therapy 
The cost estimate of the alternative policy of reviewer 1 predicted 34% savings. 
D before intervention 
• after intervention 
1000 2000 3000 4000 5000 
cost in Dfl 
Figure 2. - Costs in Dfl (IDA. = $ 0.65) of antimicrobial drugs for surgical 
prophylaxis in three departments of a university hospital before and after an 
intervention, one-month reviews. 
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However, after the intervention, overall costs of therapy increased by 15% (table 
4). This increase was due merely to higher dosage and longer duration of 
treatment, as the drugs for therapy of the new protocol were often cheaper. 
After the intervention, the cost/ therapeutic DDD was lower than before. 




After the intervention, there was a higher overall compliance with the new 
protocols than with the old guidelines (p<0.0001) (table 5). The difference was 
significant in the three departments. Parameters of quality for prophylaxis 
improved: the probability of a prophylactic course for more than 24 h decreased 
significantly in department S (p<0.0001, Fisher's exact test), but not in 
department G (p=0.16) and department O. Single dose prophylaxis increased 
(p<0.0001). The difference was significant in the three departments. The 
intervention also corrected timing, (administration within lh before surgical 
incision), which was documented in departments S and О (see chapter П). 
Agreement (ignoring category VI) between the two experts who assessed 
quality of prophylaxis before and after intervention was very good in both 
reviews (к =0.80). Therefore, only the assessment of one expert, reviewer 1, is 
discussed here and presented in table 5. There were significant differences in 
quality before and after the intervention in department G (p<0.0001), 
department S ( p<0.0001) and department О (p=0.004). 
Table 6 shows most frequent type of errors (evaluation categories II to V) by 
prophylactic drug in the first review. Oral cefalexin prophylaxis started 
postoperatively and continued for 5 days was considered unjustified (category 
V). Oral prophylaxis with neomycin/bacitracin was followed by intravenous 
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The oral prescriptions were judged unnecessary (category V). Moreover, the 
review revealed some erroneous prophylactic practices. In department S, nurses 
administered neomycin/bacitracin to all patients undergoing a bowel rinsing 
procedure, including those patients undergoing mechanical rinsing for anorectal 
operations (category V). Most oral prophylaxis (double or postoperative) were 
abandoned after the intervention. Prophylaxis with piperacillin was found too 
broad and expensive (category IV c,d). Overall, 39% of prophylactic 
prescriptions were judged to be unjustified. Their cost represented 28% of total 
prophylactic cost (table 6) and 66% of the predicted cost savings with the 
alternative policy proposed by the reviewer 1. 
Therapy 
Overall agreement between the two reviewers was much lower for therapy. This 
was true before intervention (к = 0.37), and after intervention (к = 0.30). Figure 
3 illustrates as an example, the comparison of detailed categories of evaluation 
of therapeutic prescriptions by the two reviewers before and after intervention 
in department S. It is noted that categories II, III and IV can be assigned 
simultaneously to a prescription. In department S, surgical peritonitis was treated 
by clindamycin and gentamicin in combination. Reviewer 1 considered 
cefuroxime with metronidazole a better alternative to this regimen. He thought it 
to be more effective, less toxic, and less expensive (category IV a,b,c). 
Gentamicin dosage was 80 mg 3 times daily in 17 out of 21 courses, with a 
median duration of 4.3 days. The majority of these courses were allocated to 
category Π a/b (inappropriate dose/ interval) by both reviewers. Although in 17 
courses gentamicin was given for more than 72 h, serum concentrations were 
only measured in 3 courses. Because of the overall inappropriate use of 
gentamicin, it was decided in the new protocol to reserve aminoglycosides for 
the treatment of severe sepsis only. In the second review, gentamicin courses 
had decreased by 68%. 
The new protocols had been based on the alternative policy of reviewer 1. 
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Considering the overall evaluation of 224 and 169 therapeutic prescriptions of 
the three departments, respectively before and after the intervention by reviewer 
1, the proportion of prescriptions that were considered definitely appropriate 
(category I) increased from 70 (31%) to 80 (47%). No indication for therapy 
(category V) decreased from 35 (16%) to 14 (8%). Inappropriate prescriptions 
accounted for 100 (45%) and 61 (36%) respectively. The changes were 
statistically significant (p=0.007). 
Discussion 
From the initial quality-of-use review we concluded that antimicrobial drug use 
in the surgical departments could be improved in terms of quality and costs. In 
our hospital, major misuse such as prophylaxis > 48 h, or a combination of more 
than three drugs, as cited by Kunin (10) were seldom encountered. 
Noncompliant physicians were rare. 
Prophylaxis 
The intervention succeeded in implementing a widely accepted standard of 
single dose cefazolin and metronidazole (if needed) for surgical prophylaxis. 
This type of intervention has been successful in departments of gynaecology 
and obstetrics (7, 19). The contribution of parenteral clindamycin to costs is 
known to be considerable (20). Replacement of clindamycin by metronidazole is 
known to be cost containing (21). We implemented the regimen in several 
surgical specialties for all procedures where prophylaxis was deemed 
appropriate. The intervention included the education of anaesthetists and nurses 
as well as the surgeons. The preparation and acceptance of the new guidelines 
took several months. At implementation however, the effect was sometimes 
immediate, for example, the day after the pharmacy removed piperacillin from 
one operating room drug stock. The standard regimen replaced a variety of 
broad spectrum antimicrobial drugs, previously chosen on the basis of personal 
preferences and possibly the result of promotional efforts of the pharmaceutical 
companies. The new prophylactic regimen was less costly. It was cheaper even 
in combination with metronidazole (18). Cost containment was also obtained by 
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shortening the duration of prophylaxis. Halving of the prophylactic 
cost/operation was obtained by improving quality. Compliance with guidelines 
improved, as did the result of the evaluation by the experts. Both reviewers 
agreed to a high degree upon the improvement of quality of the courses. 
Therapy 
In therapy, improvement of quality was less striking, and it was achieved at a 
higher cost. Correction of undertreatment (underase) of severe infections 
(described above) towards higher doses, parenteral route and longer duration, 
was mainly responsible for the cost increase. There was only partial agreement 
between the two experts concerning the quality of surgical therapy. Reviewer 2 
judged less therapeutic prescriptions appropriate and more prescriptions 
unjustified than reviewer 1 in all departments, before and after the intervention. 
However, his assessment also changed significantly after the intervention (data 
not given). One reason for the differences in judgment could be due to personal 
factors, reviewer 2 being more strict. Another reason could be that the new 
protocols were based on the alternative policy of reviewer 1. 
Method 
Reviews of this type are time consuming. However, the in-depth analysis 
detected many logistic problems which solving seemed crucial for the success of 
adequate prophylaxis. In prophylaxis, organizational aspects are of major 
importance, as others described recently in the U.K. (22). The in depth analysis 
also detected problems with specific drugs. The frequency in which 
aminoglycoside assays were performed in this review compared unfavourably 
with the data of another review (18% vs 78%) (23). Although amoxicillin-
clavulanate was introduced in the new protocol for one indication only, 
surgeons started to use it instead of older drugs for various other indications. 
The addition of a drug to the hospital formulary did not lead to consumption of 
the drug in surgical departments where it was not introduced in the new 
protocol (e.g, ciprofloxacin). 
We used defined daily doses (DDDs) as a unit of measurement to allow 
international comparison of the utilization data. The review showed that in 
82 
hospitalized patients, the Prescribed Daily Dose (PDD) for certain drugs can be 
quite different from the DDD, depending on the indication. When DDDs are 
used as a unit of measurement for single dose surgical prophylaxis, the 
PDD/DDD ratio should be given to estimate the number of patients treated with 
the drug. An extreme example is piperacillin which has a DDD of 14 g. In single 
dose prophylaxis with piperacillin (4 g), the PDD/DDD ratio = 0.3. Thus, for 
single dose prophylaxis, the DDD/100 bed days underestimates the population 
exposed. In severe infections, the number of patients treated with an 
antimicrobial drug can be overestimated using DDD/100 bed days as a unit of 
measurement, if the PDD/DDD ratio is not known. 
In all surgical departments, due to previous underuse, therapeutic use in DDDs 
increased while the same proportion of patients were treated with antimicrobial 
drugs. The overall proportion of patients receiving prophylaxis increased 
slightly (24 to 27%), but more of these prescriptions were judged appropriate. 
We conclude that this intervention resulted in optimizing the quality of 
prophylactic and therapeutic antimicrobial drug courses in surgical departments 
at a lower cost. Indicators of satisfactory outcome with the new policy were a 
stable median length of hospital stay and a reduction in the number of 
nosocomial infections/100 bed days treated with antimicrobial drugs. 
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CHAPTER V 
The diagnosis of infection in orthopaedic surgery. Analysis of microbiology 
laboratory utilization. 
1С Gyssens, С Smits-Caris, MVM Stolk-Engelaar, TJJH Slooff & JAA 
Hoogkamp-Korstanje. 
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Abstract 
Surgical specimens for microbiological analysis are precious because they may 
have been obtained at considerable expense to the patient, and they may not 
easily be collected again. One hundred and seventeen consecutive requests for 
microbiological analysis by a department of orthopaedic surgery were audited. 
These requests were prospectively obtained during 55 clinical episodes, 39 of 
which were of (presumed) infection and 16 of surveillance. The main sites 
sampled were joint tissue, -fluid or -bone: 28 (51%) and extraarticular bone or 
tissue: 6 (11%). Of 98 surgical specimens, 20 (20%) yielded a relevant 
microorganism. In a formal evaluation performed by 2 consultant 
microbiologists, the requests were classified as definitely appropriate in 67% 
and 85% of episodes, respectively. Collection, handling and transport were 
categorized as definitely appropriate in 56% and 73% of requests by the 2 
consultants. No request was considered unjustified. Major problems were 
underutilization in about 10% of episodes. Inappropriate sampling for 
anaerobic culture was seen in 1/4 of specimens and a prolonged transport time 
to the laboratory in 1/3. Analysis of compliance with an existing protocol for 
prosthetic joint revision revealed similar errors. We conclude that audits of this 
type can give invaluable information about the no man's land between the 
clinician and the laboratory and can identify appropriate measures for 
corrective action. 
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Introduction 
Surgical tissue specimens or puncture aspirates are precious because they may 
have been obtained at considerable expense to the patient, and they may not 
easily be collected again. Microbiological analysis of surgical specimens should 
be optimal for establishing the right diagnosis, knowledge of a pathogen and 
choice of the right antimicrobial therapy. Culture of deep tissue (for example of 
bone in osteomyelitis) often provides the only definitive information on the 
etiology of the infection (1). Isolation of the pathogen permits streamlining of 
empirically chosen antimicrobial drug therapy towards the optimal antimicrobial 
agent in terms of activity, spectrum, cost and side effects. These features, 
although relevant for all surgical specimens, are particularly important in 
revision operations for loosening of a prosthetic joint, i.e. to differentiate 
mechanical loosening from infection (2, 3). 
In order to study the quality of the entire spectrum of activity related to 
laboratory testing, the process can be divided in 6 steps: 1. ordering of the test, 
2. collection of the specimen, 3. transport to the laboratory, 4. analysis, 5. 
reporting and interpretation of the results and 6. impact on diagnosis and 
treatment (4). In the limited number of published audits of microbiological 
laboratory testing, steps 2 and 3 are not adressed. Some authors have audited all 
types of specimens, (5, 6), or cultures of urine (7), blood (8), cerebrospinal fluid 
(9) and stools (10). We are not aware of studies on surgical specimens. We 
describe an audit of microbiology laboratory use patterns in a department of 
orthopaedic surgery, with special attention to ordering, collection and transport 
of surgical specimens. 
Method and patient population 
The department of orthopaedic surgery in the University Hospital Nijmegen has 
50 beds, and approximately 1700 operations are performed annually on 
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inpatients. All consecutive requests by this department (operating room and 
wards) were prospectively gathered over 6 weeks in the microbiology 
laboratory by a technician. 
The types of orthopaedic procedures performed included arthroscopies, 
biopsies, procedures of osteosynthesis and insertion of prosthetic material. 
Data sources 
Procedures 
Requests for microbiological tests were accompanied by a form on which the 
clinician had to fill in 1) his/her name, 2) adequate clinical information and the 
use of antimicrobial drugs, 3) the nature of the specimen and ordered test, 4) 
date and time of collection. The form had to be labelled with stickers containing 
patient name, identification number, date of birth, department, ward or 
outpatient clinic. The department of orthopaedic surgery had developed a 
protocol for handling material from loose prostheses according to relevant 
literature (2, 11). The protocol included the following procedures: 4 or more 
specimens from distinct sites of the joint (synovial fluid, capsule, femur interface, 
acetabulum or tibia interface) had to be taken. For each specimen, the surgeon 
had to use sterile, not previously used forceps. Joint aspirate had to be injected 
in 2 blood culture bottles and in 1 sterile dry tube. Tissue or bone biopsies of 
lcm2 were to be collected in sterile containers. A transport box was provided 
for all containers, tubes and bottles of a single procedure. Transit time had to be 
less than 30 min. Each specimen had to be cultured for aerobes and anaerobes. 
For each type of culture (aerobic, anaerobic), a different specimen and/or 
request card had to be provided. Antimicrobial drugs had to be administered 
after the collection of specimens. 
For other materials, standard instructions for sampling and transport were used 
(12). Some of the standard instructions are cited below 
- Collection of tissue or fluid from a site presumed to be involved on 
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clinical grounds is always superior to swabs (13). 
- Large-volume fluid specimens should be inoculated in blood-culture 
bottles to enhance recovery of microorganisms (14). 
- Collection of specimens for presumed infection should preferentially 
precede treatment, as the relation between time of collection and start 
of antibiotics may have an impact on the result. (3). 
- Transit time of tissue specimens should not exceed lh, as after 1 
h recovery of anaerobes may be impaired. For urine specimens, 
refrigeration up to 8 h is considered acceptable (4). 
Clinical information 
Clinical information on the cases for whom tests were ordered was available in 
abstract form from a concurrent study of antimicrobial use (see chapter IV). The 
information was retrieved from medical records and operating room schedules 
and contained type, date and time of surgical procedures and the clinical 
presentation of infection. It also contained the antibiotic regimen for therapy or 
prophylaxis (including start and stop time) which was copied from anaesthesia 
records and medication charts (Kardex^). 
Evaluation 
At arrival in the laboratory a technician noted the time of receipt and the type of 
containers submitted. Transit time was calculated by: time of receipt in the 
laboratory minus time of collection. 
Combining the data from request cards and the data from abstracts allowed the 
allocation of multiple requests to a single clinically relevant episode of 
(presumed) infection or surveillance. 
Two consultant microbiologists performed the evaluation independently. 
Ordering was evaluated per clinical episode of (presumed ) infection or 
surveillance. Collection, handling and transport were evaluated per individual 
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request. Clinical episodes were assessed using the categories presented in table 
1, by means of evaluation criteria based on the guidelines for microbiology 
laboratory testing (12) and the advice of experts (11). Ordering practices could 
be definitely appropriate, inappropriate , unjustified, or the data could be 
insufficient for categorization. Ordering was judged inappropriate if insufficient 
clinical information was given to the laboratory, and/or if additional specimens 
or additional requests were considered necessary to establish the diagnosis. The 
evaluation categories of collection, handling and transport on the individual 
requests are presented in table 2. Requests were considered definitely 
appropriate, inappropriate, unjustified or records could be insufficient for 
categorization. Requests could also be judged inappropriate for several reasons 
at the same time: inappropriate way of collection, incorrect container or 
transport medium, prolonged transit time, or incorrect timing of collection vs 
start of antimicrobial treatment. For both evaluations, agreement between the 2 
reviewers was assessed by kappa coefficients. 
Results 
One hundred and ninety-seven orthopaedic patients were hospitalised during 
the study period. One hundred and sixty-six operations were performed. Forty-
six patients (23%) had specimens sent by 8 physicians. Four physicians were 
responsible for 77 % of requests. On 1 request, the name of the physician was 
missing. The surgeons wrote themselves the requests in the operating room 
before the start of the operation. One hundred and thirty-seven requests for 
analysis were collected in the microbiology laboratory. Twenty requests of 
bone specimens, harvested for the bone bank, were excluded from the analysis. 
Items on the card such as type of specimen and ward were filled in properly in 
more than 95%. In 19 out of 137 requests (14%), the time of collection was 
missing. Other sources permitted calculation of transit time in all but 3 requests. 
Evaluation of ordering. 
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All clinical episodes 
With the help of the clinical information, the 117 requests for clinical specimens 
could be allocated to 55 clinical episodes. Thirty-nine (71%) were episodes of 
(presumed) infection (including 8 episodes of prosthetic joint revision), 7 (13%) 
episodes had infection included in the differential diagnosis and 9 (16%) 
episodes consisted of surveillance cultures. In 13 out of the 39 episodes of 
presumed infection (33%), patients were already taking antimicrobial drugs 
prophylactically (4 patients) or empirically (9 patients) before the collection was 
done. 
The surgical sites sampled were: joint (tissue, fluid, bone) 28 (51%), extra 
articular bone or tissue 6 (11%), wound 6 (11%). Other sampling sites were 
urinary tract 11 (20%), respiratory tract and skin 4 (7%). The reviewers 
considered the information provided by the abstract of the medical record 
insufficient to perform quality evaluation in 4 clinical episodes (table 1). Both 
reviewers agreed that there was no unjustified microbiological testing (к = 1 ). 
Concerning the appropriateness of the remaining 51 episodes, there was only 
partial agreement between the 2 reviewers (к = 0.32). In 10 episodes, reviewer 1 
would have preferred more information than was provided. Reviewer 1 found 
underatilization (missing specimens or requests) in approximately 1/10 of 
episodes: in 5 episodes, another specimen of the site should have been sampled, 
and in 4 episodes, other specific tests such as tuberculosis, anaerobic culture, 
cultures for yeast or fungi should have been ordered. The ordering practice was 
judged definitely appropriate in 67% of the episodes by reviewer 1 and in 85% 
by reviewer 2. 
Prosthetic joint revision 
Eight clinical episodes for prosthetic joint revision were recorded. In 6 revisions 
the indication was loosening of the prosthesis, in 2 revisions the operation was 
done for dysfunction of the prosthesis e.c.L. Only 3 of the 8 episodes were 
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Evaluation of collection, handling and transport of specimens 
Surgical specimens 
Of a total of 98 clinical surgical specimens, 26 (27%) consisted of fluid (23 
synovial fluid), 41 (42%) of tissue, 22 (22%) of bone; 5 (5%) were wound 
swabs, 4 (4%) consisted of pus. In 72 (73%) requests, specimens consisted of 
the tissue proper, 26 (27%) specimens were sent as swabs. Twenty-five out of 
31 surgical specimens of which anaerobic culture was ordered were sent in 
anaerobic transport medium. The laboratory performed an anaerobic culture of 3 
tissue or fluid specimens, for which a single request for aerobic culture was 
provided. Thirty-four requests out of 98 were sampled during revision 
operations and were analysed separately. The remaining 64 miscellaneous 
surgical specimens consisted of 28 specimens sampled for presumed infection, 
17 specimens for surveillance and 19 specimens of which infection was included 
in the differential diagnosis. There was no growth in 57 (89%). Eight (29%) of 
the specimens cultured for presumed infection yielded a relevant microorganism. 
None of the surveillance cultures and none of the cultures where infection was 
included in the differential diagnosis were positive. However, all surveillance 
specimens and 2 out of 7 specimens of the latter group were taken after the 
administration of prophylactic antibiotics. 
The evaluation of 117 requests for clinical specimens is presented in table 2. The 
evaluation of the requests of surgical specimens was not very different from the 
total evaluation. Both reviewers judged all requests justified (к = 1). Agreement 
on the other categories was also partial (к = 0.43). All 24 inappropriately 
collected specimens were surgical specimens, as were 22 out of the 29 
specimens which had a prolonged transit time. Median transit time of all surgical 
specimens was 2 h (range 30 min - 19 h). Fifty-two (53%) surgical specimens 
had a transit time of more than 2 h and for 18 (18%) surgical specimens, transit 
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Specimens for prosthetic joint revision 
Thirty-four specimens were sent in. In 12 (35%) there was growth of a relevant 
microorganism. Again, most frequent errors were the inappropriate way of 
collecting specimens for anaerobic culture (swabs in a transport medium instead 
of tissue) and a prolonged transit time. None of the revision specimens had a 
transit time of less than 1 h. Median transit time was 3h (range: 55 min- 19 h 30 
min). On 1 request the time of collection was missing. One set of 6 specimens 
was received the morning after the intervention: the bone and tissue specimens 
were kept in a refrigerator. 
Other specimens 
The non-surgical specimens consisted of 15 (13%) urines, 2 sputa and 2 throat 
swabs. (3%). Thirteen out of the 15 urine cultures were positive, although in 2 
there was growth of < 10^ microorganisms/ml, possibly due to previous 
administration of antibiotics. The other specimens yielded non pathogenic 
bacteria. There were no blood or stool culture requests during the study period. 
Half of the requests containing insufficient clinical information were for urine 
cultures. Median transit time was 4 h 30 min (range 30 min- 16 h 30 min). Five 
specimens of secondary importance (swabs, urine) collected on pediatric wards 
had the shortest transit time (less than 1 h). 
Discussion 
We concluded that the department of orthopaedic surgery had an acceptable 
quality level of microbiology laboratory utilization. From our previous quality-
of-use studies in surgical departments (see chapter Г ), we suspected that other 
departments in our hospital were performing less well. However, we preferred 
an approach of continuous improvement (15), by auditing a department which 
had an established diagnostic protocol, instead of identifying at random such 
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errors in daily practice. 
Although the 2 reviewers agreed that there was no unjustified testing, there was 
only partial agreement concerning the definite appropriateness of ordering, 
collection and transport. Part of the discrepancy in the evaluation was due to 
different handling of the criteria. Reviewer 1 applied the criteria from the 
literature rather strictly, while reviewer 2 had a more balanced view, based on 
personal experience. 
No data from other audits are available for comparison. There are a few reasons 
for the lack of studies. Examination of the rationale behind laboratory 
utilization is not often done by consultant microbiologists, because the 
necessary clinical information for evaluation is often lacking. On the other hand, 
clinicians consider that their responsibility ends with the verbal ordering of the 
test (4). Furthermore, in large hospitals, between the operating room or the 
bedside where the decision to perform diagnostic tests is made and the 
laboratory where the specimen will be analysed, there is a wide no man's land of 
ward desks, window sills, nurse's utility rooms, corridors, dark storage places 
and, last but not least, refrigerators. 
Audits of the last 3 steps in the process of laboratory testing, (from laboratory 
analysis to interpretation of the report) have more often been done (5, 6, 16, 17). 
According to reviewer 1, the department had a certain degree of 
underutilization of the microbiology laboratory, as in 1 out of 10 episodes 
another specimen or request seemed necessary. Underutilization has been 
reported before from surgical departments (5). The practice of taking 
surveillance cultures during insertion of prosthetic material was considered 
appropriate, although the usefulness of this sampling after the administration of 
prophylactic antibiotics remains unclear (18). Only a few reports have been 
published on tests that are not useful in other settings: for example the routine 
CSF culture for mycobacteria (9) or urinary cultures in uncatheterized patients 
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receiving antibiotics (7). The optimal number of deep specimens from a 
prosthetic joint is determined as 3 to 5 (11). For blood cultures the optimal 
number of specimens is also known (8), and single sets of blood cultures have 
been proposed as indicator of unwanted outcome (19). 
The major problems revealed by the audit were improper sampling for anaerobic 
culture and prolonged transit time of surgical specimens. In a way, both errors 
may have been related. The transit time of less than 30 min stated by the 
revision protocol was practically impossible to realise, as the time between 
collection of the first and last specimen of the procedure averaged more than 1 
h. Unable to solve the logistic problem caused by the distance between 
operating rooms or wards and the laboratory and the lack of extra personnel for 
transport, the surgeons tried to overcome this problem by sending the anaerobic 
specimens as swabs in transport medium. Although this strategy may enhance 
survival of anaerobes, swabs of specimens should be discouraged when surgical 
specimens are available. Specimens with the shortest transit time came from 
wards located near the microbiology laboratory, regardless of the nature of the 
specimen. In the future, mailing by vacuum tube system might solve the problem 
of prolonged transit time from remote areas. 
The process components associated with ordering, collection and transport are 
thought to influence outcome more than the components of the internal 
laboratory process (step 4), for which quality control is mandatory in most 
countries (4). Audits of this type, conducted jointly by clinicians and laboratory 
physicians, can give invaluable information about the no man's land between 
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CHAPTER VI 
The anaesthetist as determinant factor of quality of surgical antimicrobial 
prophylaxis. 
1С Gyssens, JTA Knape, G Van Hal & JWM van der Meer. 
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Abstract 
A staff of 44 anaesthetists was interviewed by means of a questionnaire about 
the practice of surgical prophylaxis in a university hospital. Response rate was 
36/44 (82%). The anaesthetists' way of administering surgical prophylaxis was 
rather uniform and economic: cephalosporins were almost exclusively 
administered by bolus method. The main reason was that infusion was more 
cumbersome (range 77-85%). Communication between surgeon and 
anaesthetist was reported to be poor, and in two out of six operating 
departments, orders of prophylaxis transmitted at or after induction accounted 
for more than 80%. Seventy seven percent of the responders asked the surgeon 
if prophylaxis was necessary if they were in doubt; 20% responded that they 
checked it systematically. There was an association between poor 
communication reported by the anaesthetists and the late administration (after 
incision) of prophylactic antibiotics. The inquiry proved useful in the process of 
optimizing surgical prophylaxis in our hospital. 
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Introduction 
Antimicrobial drugs account for 13-37% of the drug budget in European 
hospitals; 30% is used for prophylaxis (1). Misuse is most frequently described 
with prophylactic drugs for various aspects as indication and duration (2). The 
timing of surgical prophylaxis and its organisational aspects have rarely been 
analysed. Recently, suboptimal timing of antibiotic prophylaxis was found to be 
associated with a significant higher rate of wound infections in a large series (3). 
Intravenous administration of the drug during induction of anaesthesia within 
30 minutes before incision is a generally accepted standard (4). In this situation, 
anaesthetists play an executive role in surgical antimicrobial drug prophylaxis. 
In the University Hospital of Nijmegen, + 20 000 operations were performed in 
1990. An estimated 30% of patients were receiving perioperative prophylaxis 
with antimicrobial drugs. Prophylaxis was almost exclusively started in the 
operating room. However, it was suspected that the timing of prophylaxis varied 
between surgical departments. By means of an inquiry we studied the 
anaesthetists' perception of the organisation of prophylaxis in the different 
surgical departments and their views on optimizing prophylaxis. 
Another reason to optimize antimicrobial prophylaxis is to reduce unnecessary 
costs. As we planned to implement the most economical way of administration 
of beta-lactam antibiotics ( bolus injection in 3- to 5-min) (5), we also asked the 
anaesthetists about their usual ways of administration of those antibiotics and 
the reasons for their choice. 
Methods 
All 44 staff members (seniors and residents) of the department of 
anaesthesiology who were performing anaesthesias were sent a pre-numbered 
questionnaire by internal mail in May, 1990. In our hospital, all anaesthetists 
rotated in a working schedule in all operating departments. The forms were 
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distributed and collected by JTA K, a senior staff member of the department of 
anesthesiology, who added an introductory letter, and urged on nonresponders 
for three weeks. The forms were then returned so that anonymity was preserved 
to 1С G. Thirty-nine (87%) staff members returned the form. Three returned the 
form blank. Thirty-six forms of responders ( 82 %) were used for analysis. 
The form contained three blocks of precoded questions on four pages. To fill in 
the form, only a few minutes were required. Anaesthetists were asked for their 
usual ways of administration of intravenous antimicrobial drugs for prophylaxis 
i.e. by bolus injection over 3- to 5 min or i.v. infusion over 15- to 30 min, and the 
reasons for their choice in terms of safety, time, habit and cost. They were asked 
questions about the transmission of the antibiotic order by the surgeon and its 
relation to the timing of the operation in the various operating departments of 
the hospital, both for scheduled and emergency procedures. Space was allowed 
for comments. Finally, they were asked for their attitude towards measures to 
improve the organisation of antimicrobial preoperative prophylaxis. 
Absolute and relative frequencies of responses to the questionnaire were 
tabulated. The chi-square test was used for statistical analysis. 
Results 
Thirty-six anaesthetists out of 44 responded. Considering the age classes 
younger than 35 years (n= 24, mostly residents), 35 -45 years (n= 14, mostly 
staff members) and older than 45 years (n=6, senior staff members), no difference 
in age could be found (p= 0.88) between responders and non-responders. 
Way of administration 
All anaesthetists but one administered prophylactic cefazolin and penicillins 
only by bolus injection (97%) (table 1). Gentamicin was administered only by 
bolus injection in 62 %. 
The main reasons for this choice seemed to be practicality (range 77-85%) and 
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habit (range 65-94%) (table 2). Although 48% considered i.v. infusion safer for 
gentamicin, this view did not always determine their choice of administration: 
29% gave gentamicin solely by i.v. infusion (table 1). A difference in cost was 
not a major issue; on the average, 33% thought there was no difference and 
42% had no opinion on the subject. 
Communication of prophylactic orders 
The different ways in which the anaesthetist was informed about the need for 
administration of preoperative antibiotics are given in table 3. The questionnaire 
gave five possible kinds of communications, and one "unknown". Also multiple 
replies were given. In the operating departments of surgery (SU) and 
gynaecology (GY), replies indicated that the majority of orders were transmitted 
at the earliest, at or after induction: 27.5/31 (89%) and 26.5/31 (85%) 
respectively. In the operating departments of orthopaedic surgery (OS) and 
urology (UR), about half the replies indicated late communication. In the 
operating department of otorhinolaryngology (ORL), 29.5/32 (92%), and of 
neurology (N), 18/26 (69%) of the replies indicated that the drug was sent with 
the patient. 
The question on communication between the surgeon and the anaesthetist was 
repeated for emergency (unscheduled) operations (table 4). The overwhelming 
majority of orders was transmitted at the earliest, at- or after induction of 
anaesthesia: in this situation not much difference was observed between the 
operating departments. 
Contribution to quality 
Seven out of 35 (20%) anaesthetists who replied to this part of the 
questionnaire would ask the surgeon systematically at induction about the need 
for prophylactic antimicrobial drugs. Eleven assumed that no prophylaxis was 
necessary if the surgeon did not inform them. Nevertheless, 27/35 (77%) would 
ask him if in doubt. 
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Thirty one out of 34 (91%) responding anaesthetists agreed that written 
information was necessary for the individual patient. Three thought that oral 
information would suffice. Five anaesthetists (three staff members, two residents) 
wrote comments on the deficient communication and two suggested that the 
policy of operating department ORL (preoperatively written order) be adopted. 
Discussion 
Although anaesthetists play a crucial role in the execution of antimicrobial drug 
prophylaxis in surgery in most hospitals, no studies have been performed on 
organisational aspects of that matter. The present inquiry helped us to identify 
operating departments where communication between surgeon and anaesthetist 
on antimicrobial drug prophylaxis was good and others where it was 
particularly poor. In operating departments SU, OS and ORL the timing of 
surgical antimicrobial prophylaxis was analysed in a quality-of-use review (see 
Chapter IV). There was an association between the relative frequencies of 
replies of "late" communication for the operating departments SU, OS and ORL 
in the inquiry and the delayed administration (after surgical incision) in those 
departments. 
Anaesthetists seemed to play an important role in reminding the surgeon of 
prophylaxis, as almost three quarters stated that they checked it if in doubt. 
However, such reminders occurred late in or after induction of anaesthesia, again 
resulting in a delay of prophylaxis. The variety of replies concerning 
communication of prophylaxis within some operating departments probably 
reflect a diversity of practices. For the unit ORL which sent the prophylactic 
antibiotic with the patient, replies were rather uniform, suggesting that the unit 
had a standardized policy. This was confirmed by the audit. The diversity of 
practices in the other departments was identified as a negative critical factor 
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impeding quality. We advocated a hospital-wide uniformity in the administration 
procedure of surgical antimicrobial prophylaxis. Almost all anaesthetists had a 
favourable reaction to the policy of preoperatively written drug orders by the 
surgeon. We subsequently implemented a pre-operative patient checklist that 
included the need for antimicrobial prophylaxis. 
The inquiry informed us that our plans to implement the least expensive way of 
administration of prophylactic antibiotics corresponded with the actual practice 
of the anaesthetists. Although cost factors were not perceived by the majority of 
the responding anaesthetists, we learned that other motives such as practicality 
made bolus injection already the preferred way of administration for 
prophylactic penicillins and cephalosporins. Concerning gentamicin there was a 
common but erroneous belief that slow i.v. infusion would reduce the risk for 
toxicity. However, gentamicin can be safely injected over 3- to 5 min (6), and, 
both from a pharmacodynamic and pharmacokinetic point of view, there are 
indications that high initial peak concentrations are most effective and not 
associated with higher toxicity (7). 
The results of this inquiry were used in an educational setting. We successfully 
intervened in the departments of surgery and orthopaedic surgery where poor 
timing was recorded, and optimized preoperative antimicrobial prophylaxis in 
these departments (see Chapter IV). In our hospital, this inquiry helped us to 
detect problem areas rapidly and provided us with useful information on 
practices of numerous staff. 
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CHAPTER П 
The timing of antimicrobial prophylaxis in surgery. 
1С Gyssens, IEJ Geerligs, MG Nannini-Bergman, JTA Knape, YA Hekster, & 
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Abstract 
The timing of surgical antimicrobial prophylaxis was measured before and after 
an intervention. The intervention consisted of the education of surgeons, 
anaesthetists and nurses on the subject of antimicrobial drag prophylaxis and 
the subsequent implementation of new protocols of single dose prophylaxis 
administered within one hour before incision. This prospective study was 
performed in three surgical departments of a university hospital. For comparison, 
the timing of prophylaxis was also measured in an operating department of a 
community hospital. The timing improved considerably in the departments of the 
university hospital where the intervention was carried out: optimal timing of the 
first dose administration of the first dose within one hour before incision 
increased from 39% to 69% in department A and from 64% to 80% in 
department B. Before the intervention, seven out of 16 prophylactic doses were 
given after inflation of the tourniquet. After the intervention all doses of 
prophylactic antibiotics were administered before inflation of the tourniquet. 
Initially, the intervals of multidose prophylaxis varied widely. In the second 
review, single dose prophylaxis increased from 21% to 78% in department A 
and from 31% to 85% in department B. We conclude that the intervention 
succeeded in improving the quality of surgical prophylaxis. 
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Introduction 
Timing of intravenous antimicrobial drag prophylaxis in surgery is considered to 
be optimal about 30 minutes before incision, i.e. at induction of anaesthesia (1). 
For commonly administered antimicrobial drugs, adequate concentrations are 
present in the tissues at incision and two hours thereafter (2). The rationale for 
optimal timing of prophylaxis is found in the experimental work of Burke and 
the clinical trials of Stone (3, 4). The protective effect against infection is 
maximal when the antibiotic is in the tissues before microbial inoculation occurs 
in the wound. The optimal interval is now clearly delimited to one hour before 
the incision: administration more than one hour preoperatively resulted in a 
higher rate of infectious complications (5). Recently, significantly less wound 
infections were noted in those patients to whom the drug was given 
preoperatively instead of peroperatively (i.e. within two hours after incision) (6). 
In distal limb orthopaedic surgery, the antibiotic should be injected before the 
application of the tourniquet to reach protective concentrations in the limb (7). 
Whether one or more additional postoperative doses offer any benefit is unlikely 
(8).We assessed the effect of implementing accepted guidelines for specific 
surgical procedures (1) on the quality of timing of surgical antimicrobial drug 
prophylaxis. 
Materials and methods 
Setting and patient population 
This prospective study was conducted in three separate operating departments: 
surgery (A), orthopaedic surgery (B) and otorhinolaryngology (C), of the 948-
bed University Hospital Nijmegen. The operating departments were staffed by a 
rotating pool of 40 anaesthetists. The timing of antimicrobial prophylaxis was 
registered as part of a general quality-of-use review of antimicrobial drug use in 
these departments (see chapter IV). During one month, all consecutive 
operations were reviewed; the first review was conducted in 1990, the second in 
1992. In a 326-bed community hospital, an infection control nurse (MN) 
collected data on the administration of antimicrobial prophylaxis of 500 
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consecutive operations by three anaesthetists. She used an identical method. 
Method of the review 
Time recordings of the injection of the antibiotic by the anaesthetist, of the 
induction of anaesthesia, incision and end of the operation were copied from the 
anaesthesia record after the return of the patient from the operating room. The 
anaesthesia record, (partially) computerized, allowed time recording with an 
error of at most five minutes. In the university hospital, for multidose 
prophylactic regimens lasting 24 hours or more, the times of second and third 
injections of antibiotics were copied from the patient medication sheet in the 
ward. 
Intervention 
After the first review, a report of each department was sent to their chiefs of 
staff. The report was accompanied by recommendations for an alternative 
antibiotic policy. The principal goal was to introduce a universal surgical 
prophylaxis standard of a single-dose cephalosporin for all but dirty procedures 
(2), with a second injection during the procedure for interventions lasting more 
than three hours. Cefazolin was to be given at incision (with metronidazole 
where an anaerobic spectrum was needed). The reports were discussed by the 
surgical staff, and the recommendations were formulated into new protocols for 
prophylaxis. After approval by the Antibiotic Committee, a presentation of the 
report and the protocol was held in the departments. In most departments, the 
first dose of surgical antimicrobial prophylaxis was given by the anaesthetist in 
the operating room. An inquiry (questionnaire by mail) in the department of 
anaesthesia showed deficient communication between anaesthetists and 
surgeons on the subject of administration and timing of prophylaxis and the 
wish of the anaesthetists to standardise prophylaxis (see chapter VI). The results 
of the inquiry were presented at the time of introduction of the protocols. The 
whole intervention took more than one year. The implementation of the 
protocols was assisted by junior pharmacists who organized briefings for nurses 
in the operating departments and in the wards. The standardized prophylaxis 
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guidelines were visualized in the wards and the operating rooms. Operating 
room drug stocks were reorganized. 
Outcome measures 
Two years after the first review, an identical review was performed. The effect of 
the intervention was measured in operating departments A and B, where the 
timing was found to be inadequate. The number of nosocomial infections 
(defined as active infections not present or incubating at the time of admission) 
per 100 bed days treated with antibiotics is given as an indicator of the effect of 
prophylaxis. 
Generally, chi-square tests were applied to establish systematic differences. The 
Fisher's exact test was used to compare the timing in relation to tourniquet 
application, and variance ratio F-tests for comparing variations in dosage 
intervals. 
Results 
Timing of the first dose in the university hospital 
In the first review, the timing of 276 intravenous prophylactic prescriptions was 
studied in operating department А, В and С of the university hospital. Thirty 
nine (14%) prescriptions were excluded from the analysis, because the timing of 
the first antibiotic dose was not noted or the anaesthesia record was missing. 
Prophylactic injections were divided in three groups: injections given more than 
one hour before incision, within one hour before incision, and after incision. 
There was a significant difference in the frequency distribution of the injections 
between the departments А, В and С (p<0.001). The frequency distribution of 
the injections in the departments A and В is shown in figure 1. 
The number of injections given within one hour before incision and those given 
after incision differed widely between the three departments. In department A, 
32 (39%) of the total number of injections were given within one hour before 
incision, in department В this amounted to 32 (64%) and in department С to 65 
(78%). Almost all surgical prophylaxis was administered by the anaesthetist in 
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Figure 1 - Timing of antimicrobial drug prophylactic injections in surgical 
departments before (A: n=104 and B: n=50) and after intervention (A: n=120 
and B: n=41). Time=0 is the time of incision. 
the operating room. Only the prophylactic antimicrobial drugs against 
endocarditis were administered by the nurses in the wards at 8h (i.e. often more 
than one hour before incision). Therefore, the number of injections given more 
than one hour before incision was low for all departments: 3 (3%) in department 
A, 2 (4%) in department В and 1 (1%) in department С 
In department A we looked at the differences between scheduled (n=63) and 
emergency (n=41) procedures. The timing data were not statistically different 
between both types of procedures (p= 0.94). 
In the second review, 161 prophylactic injections were studied in department A 
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and B. The timing of prophylaxis in departments A and В after intervention is 
also shown in Figure 1. In department A, the frequency distribution of injections 
was significantly different from the first review (p<0.001). In department B, no 
significant changes were obtained (p=0.15). After the intervention, almost 70% 
(A) and 80% (B) were given within one hour before incision and no injection 
was given for more than one hour preoperatively. 
Timing of the first dose in the community hospital 
In the community hospital, intravenous prophylaxis was given in 128 out of 500 
operations (26%). In 12 (9%), the time recordings of induction and/or 
intravenous administration were missing. The timing of prophylaxis was studied 
for 116 procedures. Anaesthetists administered the prophylactic drugs in the 
operating room. However, the first scheduled patient of the day was given the 
prophylactic drug by the ward nurse. Although 81 (70%) injections were given 
before the incision, 30 (26%) injections were given more than one hour 
preoperatively. Overall, there was suboptimal dosing in 56% of the procedures. 
Tourniquet Use 
In the first review, 16 procedures in the university hospital were performed 
under tourniquet control (Figure 2). In seven procedures, prophylaxis was given 
after inflation of the tourniquet. In the second review, all of eight prophylactic 
doses were administered within 30 minutes before inflation of the tourniquet 
(p= 0.054). 
Dosage Interval 
At the first review in the university hospital, we studied 100 antimicrobial drug 
regimens that were started in the operating room as prophylaxis or therapy and 
were continued postoperatively. The intervals between the first and subsequent 
doses were measured. In the wards, intravenous antibiotics were administered 
by nurses in fixed schedules of six- or eight-hourly administrations. In 
department A, patients returning from the recovery room were shifted into the 
fixed schedules without taking into account the doses given in the operating 
room. In department B, nurses calculated the correct interval by checking the 
time of the first dose on the anaesthesia record. There were 40 three times a day 
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Figure 2. - Timing of antimicrobial drug prophylaxis in surgery of the limb, 
before intervention n=16 and after intervention n=8. Time=0 is the inflation of 
the tourniquet. 
regimens in department A and 29 in department B. The distribution of the 
intervals for A and В is shown in Figure 3. 
The average interval between first and second dose was 7 h 40 min (range 0 h 
30 min - 13 h 30 min) for A and 7 h 30 min (range Ih 10 min - 11 h) for В. А 
significantly higher standard deviation was found for department A compared 
with В (p=0.01). The average interval between the second and third dose in 
ward A was 7h 45 min (range 4 to 11 hours). The standard deviation was 
significantly smaller compared with that of the first interval in A (p<0.001). 
We did not study dosage intervals in the second review as, after the 
introduction of single dose prophylaxis, only a small number of postoperative 
doses were recorded. 
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Figure 3 - Interval between first antimicrobial drag dose in the operating room 
and second postoperative dose for n=40 three times a day regimens in ward A 
and n=29 three times a day regimens in ward В (before intervention). 
Single dose prophylaxis 
Single dose prophylaxis increased from 21% to 78% (p<0.001) in department A 
and from 31% to 85%( p<0.001) in department B. In department A, two thirds of 
multiple dosing (24h) regimens were due to noncompliance with the protocol. 
One third consisted of antimicrobial use for dirty procedures. In department B, 
all multiple dosing (24h) regimens were due to noncompliance with the 
protocol. 
Discussion 
Although the optimal timing of administration of surgical prophylaxis has been 
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established a long time ago, our study shows that in daily practice, the timing 
does not seem too adequate. Suboptimal timing was recorded in a university 
hospital and a community hospital. For many patients the administration of the 
antibiotic was delayed until late in the course of the procedure. The prophylaxis 
timing data of distal limb surgery were particularly shocking, since it has been 
shown in an animal model that no adequate drug concentrations can be attained 
in the distal tissues after inflation of the tourniquet (7). Our intervention started 
with the reporting of the data to the surgeons and anaesthetists. The review 
reports, several meetings with the staff and finally, the implementation of new 
guidelines succeeded in optimizing the timing of the first dose. In the second 
review, the tourniquet control timing data were all within the correct range. 
The inquiry in the department of anaesthesiology showed the importance of 
communication between the surgeon and the anaesthetist. In the departments A 
and В where the anaesthetist was informed by the surgeon about the need for 
prophylactic drugs after the induction of anaesthesia (see chapter VI), the 
percentage of injections of prophylactic drugs after surgical incision was high. 
Delayed administration of prophylaxis was found not only in the large-scale 
setting of the university hospital, but also in the community hospital, suggesting 
that this might be a general problem. The administration of prophylactic drugs 
when the patient is called to the operating room and is given premedication - as 
happened in the community hospital -, often resulted in doses given for more 
than one hour preoperatively. Department C, where the prophylactic drug was 
sent with the patient to the operating room, seemed to score best for the timing 
of the first dose. This strategy was applied in department В after intervention, 
but did not result in significant improvement. 
Our data in department A showed widely varying intervals between the first and 
second prophylactic dose and therefore resulted in weird pharmacokinetics and 
probably inadequate prophylaxis. Patients returning at irregular time points from 
the operating room to the wards were administered the second dose following 
the fixed medication times - for example 6h-14h-22h - in eight-hourly regimens. 
Once the patient remained in the ward, the regular time schedule of the nursing 
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staff provided good quality of prescribing, as was described by others (9). 
In 1990, many surgeons adhered to 24 hours prophylaxis regimens, because 
they felt it to be unsafe to switch to a single dose regimen. The inconsistency of 
the 24-hours prophylaxis practices revealed by the review helped us to 
convince the staff to implement protocols of single dose regimens. In the second 
review, all surgeons used single dose prophylaxis, although some of them 
continued to use 24h prophylaxis in selected cases. 
Optimizing of the timing results in a reduction of wound infection rates as 
shown by Classen (6). In our study, not only the timing, but also the choice of 
drug and duration of prophylaxis changed after the intervention, following the 
guidelines for optimal prophylaxis (1). Although we did not prospectively study 
the incidence of postoperative wound infections during the study periods, there 
are some indicators that the new policy improved the quality of prophylaxis. 
The number of nosocomial infections treated with antibiotics /100 beddays was 
1.38 in the first study period and 0.90 in the second. The average length of stay, 
as an indicator of postoperative infectious complications, has continued to 
decrease since 1986. 
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Abstract 
Antimicrobial drug use was prospectively analysed in the department of 
internal medicine of a 948-bed university hospital. Following an initial quality-
of use review of all consecutive antimicrobial drug courses during four weeks, 
an educational programme was conducted. In search for an appropriate 
surveillance method, an antibiotic order form was introduced. Four years after 
the first surveillance, an identical review was done. Quality was evaluated 
using established criteria. 
In the first review, 109/347 (31%) of the patients were prescribed antimicrobial 
drugs, 94% of which were for therapy. The quality of only 40% of the 
prescriptions was definitely appropriate, and 13% were considered unjustified. 
There was a certain degree of underutilization, and only 67% of clinical isolates 
were susceptible to empirical therapy. 
In the review after intervention, 164/796 (21%) patients were treated with 
antimicrobial drugs, of which 83% was for therapy. There was an increase in 
DDD/100 bed days from 59.8 to 72.6 between the two reviews. The 
consumption of antiviral and antifungal drugs doubled. Fifty three percent of 
the prescriptions were judged optimal, and only 9% were judged unjustified. 
Ninety percent of the clinical isolates were susceptible to empirical therapy. 
One year after introduction, the compliance with the antibiotic order forms on 
voluntary basis in two units was 77% and 50 % respectively. As correctly 
predicted by our first evaluation, improvement in quality resulted in an increase 
in antimicrobial drug consumption for fewer patients and a higher total cost per 
bed day. Thus, our study shows that combined interventions lead to improved 
quality. The antibiotic order form proves useful for antimicrobial drug 
surveillance in European hospitals, provided logistic support of the pharmacy. 
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Introduction 
Increasing costs of antimicrobial drug consumption, reports on inappropriate 
use of antimicrobial drugs (1,2) and the worldwide increase in resistance (3) are 
the main incentives for antibiotic policy measures of the nineties. Recently, 
national antimicrobial drug consumption data from European hospitals have 
been published by Janknegt (4). Dutch university hospitals seemed to have a 
rather low consumption of antimicrobial drugs (44.3-46.6 DDD/100 bed days) 
compared with German and Belgian hospitals and this seems to be reflected by 
lower resistance rates in the Netherlands. However, little is known about the 
quality of use. 
Criteria for evaluation of therapy and prophylaxis with antimicrobial drugs are 
well established (5, 6). Many strategies to improve the quality of prescribing 
have been described. Education as single intervention strategy to improve 
quality has not always been successful (7). Antibiotic order forms filled in by 
prescribers have been used to monitor use and to influence prescribing habits 
in the U.S. (8, 9), but the experiences in Europe are very limited and 
unpublished. 
We studied the use of antimicrobial drugs in the department of internal 
medicine of a large university hospital. The intervention study was designed: 1) 
to define the patterns of antimicrobial drug use in terms of quality and costs 2) 
to measure the effect of an educational programme and 3) to measure the value 
of an antibiotic order form. 
Patients and Methods 
Study population, study period and trends 
The University Hospital Nijmegen is a 948-bed teaching hospital. The 
department of internal medicine counts 183 beds in several subunits (table 1). 
Some of these subunits were highly specialised, such as the units of 
haematology and nephrology, where organ transplants were performed, and 
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most patients were taking immunosuppressive drugs and/or corticosteroids. 
There was also a large unit of general internal medicine with an older patient 
population. The study started with an antimicrobial drug use review in October 
1989. In October 1993 a similar review was performed. Between the two 
reviews, the number of beds had remained unchanged. The number of kidney 
and allogeneic bone marrow grafts had increased from 90 and 26 in the first 
study year to 111 and 38 in 1993 respectively. 
Utilization reviews and antimicrobial drug supply 
In the first review, performed over four weeks, all the units of internal medicine 
were studied (table 1). The second review was conducted over six weeks in 
three selected units. The units I (general internal medicine) and N (nephrology) 
were selected to measure the effect of an educational programme and antibiotic 
order form, while the unit of pulmonary diseases (P), where no order form had 
been used, was studied as a control. 
At the time of the first review, the hospital formulary listed 20 parenteral and 26 
oral antimicrobial drugs. In that year, antimicrobial drugs accounted for 22% of 
the total drug budget of Dfl 14 million. Hospital formulary drugs were kept in 
ward-based stocks. Pharmacy technicians supplied the drugs to the wards on a 
twice-weekly basis. Non formulary drugs had to be ordered from the pharmacy 
on special orders for individual patients. Computerized consumption figures 
were available for different wards, but not for individual patients. Between the 
two reviews, an update of the antimicrobial drug formulary was issued, and five 
antimicrobial drugs were added to the formulary: amoxicillin-clavulanate, 
ciprofloxacin, trimethoprim, fluconazole and itraconazole. Five older drugs 
were removed. 
Method of the review 
Prospective quality-of-use studies were performed by an infectious diseases 
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physician and junior clinical pharmacists, who visited the wards and collected 
data on all patients receiving antimicrobial drugs on a daily basis. The first 
review was conducted over four weeks, the second review over six weeks. 
Abstracts were made of each consecutive antimicrobial drug course. A course 
was defined as an episode of clinical or suspected infection or increased risk of 
infection, in which prescription(s), either consecutively or in combination, were 
written to treat or prevent this particular infection. Clinical information was 
retrieved from the patient's record. Infections were defined according to CDC 
(10). Nosocomial infection was defined as active infection that was not present 
or incubating at the time of admission. The schedule of systemic drug therapy 
was copied from the patients' medication chart (Kardex®). Antimicrobial drag 
use was analysed quantitatively, and converted in defined daily doses (DDD). 
The DDD represents the average therapeutical dose for an adult for the 
standard indication (11). Quantitative use of a drug in DDD /100 bed days has 
been chosen by the WHO drug utilization group to compare use in hospitals 
(12). Costs were calculated in guilders (Dfl) by a method for global drug cost 
calculation, which includes costs of administration and monitoring (13). 
Microbiology results (culture reports and serum antibiotic concentrations) were 
obtained directly from the department of medical microbiology. 
A quality evaluation of individual prescriptions was performed by two 
independent experts in infectious diseases. The method is based on the original 
criteria of Kunin (5) and is described previously (6). In short, prescriptions can 
be categorized as definitely appropriate (category I), unjustified (category V) or 
the records can be insufficient for categorization (category VI). The other 
prescriptions are placed in categories of inappropriate use II, III, and IV. 
Inappropriate prescriptions can be allocated to several categories at the same 
time: incorrect dose (Па), interval (ПЬ) or route ( Пс), duration too long (Ша) or 
too short (Iïïb). If relevant, the reviewers cite a better alternative agent due to 
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higher efficacy (Г а), lower toxicity (category IVb), lower cost (category IVc) 
and less broad spectrum (IVd). Global costs of actual and alternative policies 
are compared to project savings by changes in policy. Because only one 
expert, reviewer 1, was involved in the education and policy changes during 
the intervention, detailed evaluation results will be presented of reviewer 1 
only. 
A few parameters of quality were recorded separately: mentioning in the 
medical record of the suspected microorganism in empirical therapy, and the 
monitoring of potentially toxic antimicrobial drugs. We equally checked if the 
isolated microorganism was susceptible to the empirically started drug, and if 
streamlining was done after microbiology results became available. 
Intervention strategies: education and an antibiotic order form 
The principal goal of the interventions was to improve quality of use. Sessions 
of clinical case reviews were organised on a weekly basis from 1989 through 
1992 and could be attended by all residents in internal medicine. In addition to 
the educational programme, an antibiotic order form was introduced in units I 
and N in 1992 (see chapter IX). On the order form, the physicians were asked to 
categorize prescriptions as prophylaxis, empiric therapy or directed therapy. 
They had to state the (presumed) site of infection, (presumed) causative 
microorganism, planned duration of the course and parameters such as weight, 
serum Creatinin and presence of allergy. A limited number of formulary 
antimicrobial drugs and dosage regimens was printed on the form and could be 
ticked off. 
Generally, χ2 tests were applied to establish systematic differences. Agreement 
between the experts was assessed by к coefficients. 
Results 
First review 
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- all units of the department of internal medicine 
Overall, 173/569 (30%) patients received antimicrobial drugs (table 1). 
Antimicrobial drug use varied considerably and ranged from 9% of the patients 
in the unit of cardiology to 86% of the patients in the unit of haematology. 
Table l(left) shows the proportion of the patients treated with antimicrobial 
drags for 7 units, and the proportion for a subpopulation of patients > 70 years 
old. In the units of haematology and nephrology, none of the patients were 
older than 70 years. In the 5 remaining units, 22% of the patients were older 
than 70 years. In these units, a higher proportion of the older patient group 
received antimicrobial drugs compared with the younger group, 30% vs 20% 
(p=0.02). Patients > 70 years were almost exclusively prescribed formulary 
drugs (99%), compared with the younger population, for whom 85% of the 
antimicrobial drugs were formulary drugs (Fisher's exact test, p=0.001). 
Seventy-eight DDD/100 bed days were prescribed in the entire department. 
The unit of haematology was the largest consumer with 437 DDD/100 bed 
days. The mean consumption of the other units was 49 DDD/100 bed days. The 
majority of antimicrobial use was categorized as therapy, except in the unit of 
haematology, where 35/68 (51%) of the courses were categorized as 
prophylactic. This prophylaxis was administered to neutropenic patients 
according to standardised protocols. 
The overall most frequent type of infection treated with antimicrobial drugs 
was respiratory tract infection (34% of the courses). The range for the different 
units was 27-78%). In the units of oncology and nephrology urinary tract 
infections were most frequent, 3/10 (30%) and 12/37 (32%) respectively, and in 
haematology courses in patients with neutropenia and fever accounted for 
13/33 (39%). Overall cost/bed day was Dfl 24.4. In the units of haematology 
and nephrology, antiviral and antifungal agents contributed to 42% of all 
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selected units I, N and Ρ 
Detailed analysis of the data from the selected units: general internal medicine 
(I), nephrology (N) and pulmonary diseases (P), is presented in table 2 to 6 to 
allow comparison with the data of the second review. 
Quantitative use 
In the first review in the selected units, 109/347 (31%) of the patients were 
administered antimicrobial drugs (table 1). There was a large difference in 
consumption between unit I and both units N and P, where more than half of 
the patients were treated with antimicrobial drugs. Overall concomitant use of 
corticosteroid drags was 45%, and use of immunosuppressive drugs amounted 
to 27%. The patients in unit N had the highest consumption in terms of 
courses/100 bed days, but due to renal function impairment, most patients had 
dose reductions which resulted in a relatively low consumption expressed in 
DDD/100 bed days (table 2). Unit Ρ had the highest consumption in DDD/100 
bed days, and more than three quarters of the drugs were administered orally, 
whereas in the other units, the majority of the drugs were given parenterally. 
Indication 
The courses were almost exclusively categorized as therapy (table 2).The types 
of infections treated with antimicrobial drugs are presented in table 3. 
Respiratory tract infections were the most frequent type of infections treated 
with antimicrobial drugs (39%). Thirty-three percent of all infections treated 
could be classified as nosocomial. The consumption of therapeutic antimicrobial 
drugs, divided in major groups and expressed in DDD/ 100 bed days, is 
presented in table 4. Penicillins accounted for half of the overall consumption. 
Antifungal and antiviral drugs accounted for 16%. 
Costs. 
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cost/bed day. Although unit N used expensive drags, total cost/bed day and 
cost/course was relatively low due to previously mentioned dose adaptations 
for impaired renal function. One course cost on average Dfl 293. The cost 
distribution of antimicrobial drugs of unit I, N and Ρ is given in figure 1. More 
than half of the costs were made for cephalosporins and penicillins. 
in % total DDD in % total cort 
before intervention before intervention 
in % total DDD 
after intervention 
. 3 % 
after intervention 
39% 
in % total cost 
11% 
Ш antiviral drugs 
Η penicillina 






Figure 1 - Distribution of antimicrobial drug consumption in the department of 
internal medicine before and after intervention. Left: distribution in % total 
DDD. Right: distribution in % total cost. 
Qualitative aspects. 
Causative organisms 
The most frequently isolated microorganisms were Escherichia coli and 
Klebsiella spp. (20%), and staphylococci (Staphylococcus aureus 6% and 
Staphylococcus epidermidis 6%). In figure 2 the relationship between 
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antimicrobial drug prescribing and microbiology laboratory utilization is drawn. 
Microbiology laboratory testing could be studied in 123/127 therapeutic 
courses of which the site of infection was known. In three quarters of these 
courses microbiology tests were performed. The tests yielded a relevant 
microorganism in 69%. Only 67% of these microorganisms were susceptible to 
the empirically started drugs. In less than half of the courses where the 
microorganism was not susceptible, therapy was changed to an adequate 
spectrum. Streamlining of empirical therapy was done in 46%. 




microbiological tests performed no microbiological tests performed 
94 (76%) / 128 (83%) 29 (24%)/26 (17%) 
no (relevant) microorganism isolated relevant microorganism isolated 
29 (31%)/53 (41%) 65 (69%) / 75 (59%) 
I 
relevant isolate and empirical therapy given 
„ 39 (60%) / 39 (52%) 
microorganism susceptible microorganism not susceptible 
26 (67%)/35 (90%) 13(32%)/4(10%) 
l i 
therapeutic move (stop) therapeutic move (streamlining) change to adequate choice 
7(24%)/6(11%) 12(46%)/14(40%) 6(46%)/4(100%) 
Figure 2 - Microbiology laboratory utilization by the department of internal 
medicine and the impact of the laboratory results on prescribing. Only 
therapeutic antimicrobial drug courses were studied; n=123 before intervention, 
n= 154 after intervention. 
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Quality evaluation of individual prescriptions 
Figure 3 summarizes detailed categories of evaluation of all prescriptions by the 
two reviewers. Two hundred and fifty-nine prescriptions could be evaluated. It 
is noted that categories II, III and IV can be assigned simultaneously to a 
prescription. There was only moderate agreement (ignoring category VI) 
between the reviewers (κ=0.40). Agreement was higher when only categories I 
(definitely appropriate) and V (unjustified) were considered (κ=0.56). Reviewer 
2 judged more prescriptions unjustified than reviewer 1, and this was true for the 
three units. He also judged less prescriptions definitely appropriate. 
Table 6 shows the results of the evaluation by reviewer 1 for the three units. 
Less than half of the prescriptions were definitely appropriate (category I), and 
13% were judged unjustified (category V). Thirty-seven percent of prescriptions 
could be optimized (category II-IV). 
Cost projections were made. Elimination of prescriptions judged as unjustified 
by reviewer 1 would result in savings of only 8%. The low frequency of less 
costly alternatives (category IVc) 5 %, or alternative with less broad spectrum 
(category IV d) 3%, did predict minor savings. Moreover, because duration of 
therapy was almost never considered too long (category Ilia) and was even 
judged too short (category III b) in 2 %, no savings were expected by an 
improvement in prescribing. Finally, the combination of category II a (incorrect 
dose, mostly too low) 15%, category Г a (more effective alternative wanted) 
19%, and only 68% of microorganisms susceptible to empirically started drugs, 
suggested the need for higher doses of drugs with a broader spectrum. It was 
anticipated that implementing the policy of reviewer 1 would result in cost 
increase. 
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Other quality parameters 
In 16/70 (23%) of empirical courses the suspected microorganism was 
mentioned in the medical record. Unit Ρ scored best with 6/16 (38%). Formulary 
drugs were used in 86% (88% in unit I, 76% in unit N, 93% in unit P). In all 12 
courses of gentamicin lasting >72h, serum concentrations were measured. 
Courses were given as three times daily regimens. In 4/12 a peak concentration 
<5 mg/1 was measured (considered too low) and in 4/12 a trough concentration 
of >lmg/l (considered too high). In all courses the dose and/or frequency was 
adapted. In 3 courses the second peak concentration was still below 5mg/l. 
Intervention and surveillance over the years 1990-1992 
Surveillance data of the pharmacy showed that expenses for antimicrobial drugs 
had remained stable in 1990, but had increased by 35% in 1991 and 45% in 
1992 in the units I and N. In those units, the average length of stay had 
decreased by one day between 1989 to 1993. 
The purchase cost of most antimicrobial drugs decreased between the two 
reviews. The cost of cephalosporins decreased by 10 % and the cost of 
ciprofloxacin and vancomycin by 25%. The antifungal drugs fluconazole and 
itraconazole that were used on compassionate use basis in the first review, 
became part of the hospital formulary, resulting in a cost increase for antifungal 
drugs. To analyse the consequences of those complex cost changes, a second 
in-depth review was done. 
Changes in the second review 
Quantitative use 
Comparing the units I, N and Ρ in which both reviews were held, there was a 
reduction in the overall proportion of patients receiving antimicrobial drugs, 
from 31% to 21% (table 1). The difference was significant in unit I (p=0.006) 
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and unit N (p=0.002), but not in unit Ρ (p=0.25). Overall concomitant use of 
corticosteroid drugs was 48%, and use of immunosuppressive drugs amounted 
to 23%. Table 2 shows the comparison of quantitative data. Overall 
consumption increased, both in terms of courses/100 bed days and in terms of 
DDD/ 100 bed days. The proportion of parenterally administered drugs 
decreased only in unit N. Part of these quantitative changes could be explained 
by a policy change in unit N (as discussed below). 
Indication 
Six percent of the courses was intended for prophylaxis in the first review and 
17% after intervention (table 2). This consumption increased mainly because the 
department of nephrology started post transplantation prophylaxis with 
cotrimoxazole against Pneumocystis carinii. Eighteen percent of the patients in 
unit N were on prophylaxis with cotrimoxazole. 
Respiratory tract infections were still the most frequent type of infections 
treated with antibiotics (table 3), and the sites of infection were very similar. The 
consumption of penicillins, cephalosporins and aminoglycosides remained stable 
(table 4). There was an increase in the use of combinations of trimethoprim with 
sulfonamides in unit N. Antiviral and antifungal drug consumption doubled and 
the remaining increase was merely due to slight changes in a variety of 
antimicrobial agents. The consumption of amoxicillin-clavulanic acid, and 
ciprofloxacin, drugs that were added to the formulary in 1991, did not increase. 
Combinations of two or more antimicrobial drugs were less frequently seen in 
the second review (table 2). 
Costs. 
Comparison of the cost distribution of antimicrobial agents before and after 
intervention is shown in figure 1. The increase in prophylaxis had only minor 
influence on the cost, as the drugs used were oral and of low cost 
(approximately 4% of total cost). Comparison of cost parameters before and 
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after the intervention is shown in table 5. The total cost/bed day increased from 
Dfl 13.2 to 19.9. The increase in cost/bed day was seen in each of the three units, 
although most pronounced in unit I and unit P. A higher cost/DDD, representing 
the use of more expensive drugs, and a higher cost/course were noted in unit I 
only. 
Validation of the antibiotic order form 
During the second review, the data on the antibiotic order forms of units I and N 
were compared with the data collected by the in-depth method. 
Defining compliance as the total number of antibiotic order forms collected/ total 
number of prescriptions, compliance was 77% in unit I and 50% in unit N. In 
98/170 (58%) courses, at least one order form was filled in. At least one form was 
filled in for 39% of prophylactic courses and for 61% of therapeutic courses. In 
unit I, 86% of total antimicrobial drug costs were documented by order forms. In 
unit N, this only amounted to 41%. Categorization in prophylaxis or therapy 
and site of infection were well documented in 98% in unit I and in 90% in unit 
N. In empirically started therapy, a suspected agent was mentioned in 70% and 
62% respectively. However, some items were regularly omitted. History of 
allergy was most frequently left blank (44%), followed by weight 41%, and 
Creatinin 31%. Only 33% of forms were filled in without blanks. In 98% of the 
forms, the formulary drugs preprinted on the form were chosen. In unit I, on 80% 
of the forms, preprinted doses and dosage intervals were ticked off. In unit N, 
only 33% of the preprinted regimens were used. This was probably due to dose 
and/or dosing interval adaptations for impaired renal function, although this 
reason was only mentioned on half of those forms. 
Quality 
Causative microorganisms 
The utilization of microbiological tests in therapeutic courses increased from 
76% to 83% in the second review (Figure 2). The yield of relevant 
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microorganisms was lower in the second review (59% versus 69%). After the 
intervention, 90% of the isolates were susceptible to the empirical therapy, 
compared with 67% before intervention. All empirical therapy was changed to 
an adequate spectrum after culture results were known. 
Quality evaluation of individual prescriptions 
Three hundred and thirty-two prescriptions could be presented for evaluation. 
Figure 3 allows comparison of detailed categories of evaluation of all 
prescriptions by the two reviewers before and after intervention. After the 
intervention, agreement (ignoring category VI) between the reviewers was only 
partial (K=0.27). Again, reviewer 2 considered more prescriptions unjustified 
than reviewer 1. He also judged less prescriptions definitely appropriate, and this 
was true for the three units. 
Comparison of the quality evaluation for the three units by reviewer 1 before 
and after the intervention is shown in table 6. According to reviewer 1, the 
overall proportion of prescriptions that were considered definitely appropriate 
(category I) increased from 40% to 53%. Unjustified prescriptions (category V) 
decreased from 13% to 9%. There were relatively less prescriptions classified in 
categories II to IV (inappropriate). The differences were statistically significant 
for the total prescriptions (p=0.01). There were also significant differences in 
quality before and after the intervention in unit I (p=0.003) and unit N 
(p=0.002), but not in unit Ρ (p=0.91), where no order form was used. According 
to reviewer 2, there were significant differences in quality before and after the 
intervention in unit N only (data not given). 
After the intervention, 96% of the antimicrobial drug prescriptions were 
formulary drugs in unit I and N. In unit Ρ this amounted to 89%. 
Discussion 
The first analysis of antimicrobial drug use in this department of internal 
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medicine showed that, although there was no major misuse, quality could be 
optimized. We projected that, due to a certain degree of underutilization, 
implementing a policy to improve quality would result in cost increase. 
Although quantitative use in terms of DDD/100 bed days increased after the 
intervention, the proportion of patients who were receiving antimicrobial drugs 
was lower than before. This can be explained by the use of higher dosages 
and/or longer duration of treatment restricted to patients with proven infections, 
and the shorter length of stay. Total cost/bed day increased for the same reason, 
and also due to the use of drugs with a broader spectrum (thus more expensive, 
and increase in cost/DDD). The higher proportion of older patients receiving 
antimicrobial drugs was consistent with the finding of Moss et al. (14). However, 
in contrast to what was found in the British study, there was a more prudent 
use. There was only partial agreement between the two experts who evaluated 
quality of use. Personal factors (reviewer 2 was more strict for all units) may 
have played a role, but also the fact that reviewer 1 was involved in the 
development of the new policy. 
To the best of our knowledge, this is the first report in the English language 
literature on the use of antibiotic order forms in Europe. Quality improved in 
units N and I where the antibiotic order form was used. As we combined several 
intervention strategies (education, update of the formulary, antibiotic order 
forms), it was not possible to estimate the effect of each intervention separately. 
The effect of a compulsory formulary must on its own be considerable. Even 
before the introduction of the order form, a separate order had to be sent to the 
pharmacy for non formulary drugs. This resulted in a very high compliance with 
the formulary of 86% before the use of the order form, and also in unit Ρ in the 
second review. The order form was successful in stimulating wanted dosing 
frequencies as was found in unit I. This effect of the order form has been 
described by others (9). Another advantage of the form is that the suspected 
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causative microorganism has to be explicitely mentioned on the form. Without 
an order form it is otherwise not clear if the prescriber does not know the 
suspected agent or fails to mention it in the record, unless the prescriber is 
interviewed. 
The order form may thus have had an effect on quality, but its main purpose was 
surveillance. The in-depth reviews were very time-consuming. The order form 
was generally well accepted by prescribers. In terms of surveillance, the form 
was successful in unit I with a high voluntary compliance of more than 75% and 
a coverage of more than 80% of antimicrobial drug costs. Compliance with the 
form can probably be improved by making the form mandatory and controlled 
by the pharmacy (15). 
When antimicrobial drug use is expressed in DDD, comparisons can be made 
between hospitals (4, 16), but also within hospitals and in the same department 
over time, regardless of the types of antimicrobial drugs used. In our hospital, 
consumption was higher in internal medicine than in the department of surgery, 
where consumption was 31 DDD/100 bed days for therapeutic courses (see 
chapter IV). 
Our method of quality evaluation, although time-consuming, proved effective 
for an initial review. Furthermore, the method could predict the effect of policy 
changes on costs. The antibiotic order form was only partially successful on a 
voluntary basis, although well accepted by physicians. With support of the 
hospital pharmacy, i.e. by making the form mandatory and by taking actions in 
case of noncompliance, the form could be a useful tool for antimicrobial drug 
surveillance in European hospitals in the future. 
References 
1. Kunin CM, Staehr Johansen K, Worning AM, Daschner FD. Report of a 
Antimicrobial drug use in internal medicine 151 
symposium on use and abuse of antibiotics worldwide. Rev Infect Dis 1990;12:12-
19. 
2. Dunagan WC, Woodward RS, Medoff G, et al. Antibiotic misuse in two clinical 
situations: positive blood culture and administration of aminoglycosides. Rev Infect 
Dis 1991;13:405-412. 
3. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial 
era. Science 1992;257:1050-1055. 
4. Janknegt R, Wijnands WJA, Caprasse M, Brandenburg W, Schuitenmaker MG, 
Stobberingh E. Antimicrobial drug use in hospitals in the Netherlands, Germany and 
Belgium. Eur J Clin Microbiol Infect Dis 1993;12:832-838. 
5. Kunin CM. Use of antibiotics: a brief exposition of the problem and some tentative 
solutions. Ann. Int. Med 1973;79:555-560. 
6. Gyssens 1С, Van den Broek PJ, Kullberg В J, Hekster YA, Van der Meer JWM. 
Optimizing antimicrobial therapy. A method for antimicrobial drug evaluation. J 
Antimicrob Chemother 1992;30:724-727. 
7. Jones SR, Barks J. The effect of an educational program upon hospital antibiotic 
use. Am J Med Sci 1977;273:79-85. 
8. Avom J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M. Reduction 
of incorrect antibiotic dosing through a structured educational order form. Arch 
Intern Med 1988;148:1720-1724. 
9. Lipsy RJ, Smith GH, Maloney ME. Design, implementation, and use of a new 
antimicrobial order form: a descriptive report. Ann Pharmacother 1993;27:856-861. 
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for 
nosocomial infections, 1988. Am J Inf Control 1988;16:128-140. 
11. Anatomical Therapeutic Chemical (АТС) Classification index, including Defined 
Daily Doses (DDDs) for plain substances. WHO Collaborating Centre for Drug 
Statistics Methodology, Oslo, January 1993. 
12. Staehr Johansen K, Storgaard M, Carstensen N, Frank U, Daschner F. An 
international study on the occurence of multiresistant bacteria and aminoglycoside 
consumption patterns. Inf 1988;16:313-322. 
13. Gyssens 1С, Lennards CA, Hekster YA, Van der Meer JWM. The cost of 
antimicrobial chemotherapy. A method for cost evaluation. Pharm Weekbl Sci 
1991;13 (6):248-253. 
14. Moss F, McNicol MW, McSwiggan DA, Miller DL. Survey of antibiotic prescribing 
152 
in a district general hospital I. Pattern of use. The Lancet 1981 ;ii:349-352. 
15. Echols RM, Kowalsky SF. The use of an antibiotic order form for antibiotic 
utilization review: influence on physicians' prescribing patterns. J Inf Dis 
1984;150(dec):803-807. 
16. Friis H, Mortensen N, Pinholt H, Schmidt K, P. S, Waarst S. Regional variation in 
the use of antibiotics in four Danish Hospitals. Infection 1989;17:139-141. 
Antimicrobial drug use in internal medicine 153 
CHAPTER DC 
Feasibility of an antibiotic order form in internal medicine. 
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Abstract 
Inadequate control of antimicrobial drug use may lead to excessive expenditure 
for antimicrobial drugs and improper prescribing. It may also result in the 
emergence of multiresistant bacteria. An antibiotic order form may improve the 
quality of prescriptions by increasing the awareness of the physician of the 
antimicrobial spectrum needed (i.e. which microorganism is expected in a given 
patient), the desired duration of treatment, the potential need to adjust dosage, 
and the potential allergy of the patient to the drug. Furthermore, such an 
antibiotic order form facilitates prospective evaluation of both the quantity and 
the quality of prescribing practice. However, the introduction of yet another 
form to fill in may meet with opposition from prescribers. We have developed an 
easy-to-use antibiotic order form that incorporated the conventional medication 
order that was already in use in our hospital. Compliance (percentage of 
antimicrobial drug prescriptions for which an order form was used) rose from 
58% in the first two weeks after introduction to 76% over the following half 
year. Data retrieved from the antibiotic order forms could be used for 
surveillance. We conclude that this antibiotic order form was feasible in a large 
department of internal medicine of a university hospital. Future usefulness will 
depend on compliance and on personnel support for data processing and 
intervention. 
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Introduction 
Inadequate control of antimicrobial drug use may lead to excessive expenditure 
for antimicrobial drugs and improper prescribing. It may also result in the 
emergence of multiresistant bacteria that threaten both the patient receiving the 
antimicrobial drug and other patients in the hospital (1, 2). Education and 
guidelines or restrictions on the availability of antimicrobial drugs may improve 
the quality of prescribing (3). 
Durbin et al. were the first to introduce an antibiotic order form. The order form 
was designed to encourage the physician to review basic clinical and laboratory 
information and to categorize antimicrobial drug use as prophylactic, empirical 
(culture results not available), and therapeutic (4). Use of the order form was 
mandatory, i.e. antibiotics were delivered to the patient only if the form was 
completed. Furthermore, antibiotics were automatically discontinued by the 
pharmacy after a predetermined number of days depending on the indication. 
Over the past ten years, further experience with the form was reported from 
several US hospitals (5-12). An antibiotic order form may improve the quality of 
prescriptions by increasing the awareness of the physician of the desired 
antimicrobial spectrum, i.e. which microorganism is suspected in a given patient, 
the desired duration of treatment, the potential need to adjust dosage, and 
potential allergy of the patient to the drug (7, 9, 13, 14). By filling in the 
antibiotic order form, the prescriber provides himself the data for drug utilization 
surveillance. In return, the antibiotic order form facilitates prescribing by 
providing information on the formulary drugs and preferred dosing regimens at 
the time of prescription. However, the introduction of uniform prescription 
guidelines and yet another form to fill in may meet with opposition from 
prescribers. Therefore, we investigated physician's acceptance of and 
compliance with an antibiotic order form. In addition, an attempt is made to 
evaluate the quality of antimicrobial drug prescriptions with help of the 




The order form was introduced in the departments of general internal medicine, 
gastroenterology, nephrology, and endocrinology of the 948-bed University 
Hospital Nijmegen, in the course of an intensified education program on the use 
of antimicrobial drugs. Total number of beds in these wards was 100. Most of 
the prescriptions were written by nine residents, who were supervised by six 
internists. Data are presented on the first seven months following the 
introduction of the antibiotic order form. 
Drug supply and antibiotic order form. 
In the University Hospital Nijmegen, the pharmacy delivered formulary drugs for 
inpatients to the wards on a twice-weekly basis. Computerized drug 
consumption data were available per ward level, but not for individual patients. 
Formulary drugs were kept in ward stocks, that were managed by nurses. Non 
formulary drugs had to be ordered on individual prescriptions and were directly 
controlled by the pharmacy. Formulary drugs for individual patients were 
prescribed on medication orders consisting of a strip of paper and duplicate 
sticker that was pasted on the patient's Kardex medication card. The strips were 
kept in the patient's nursing record, and the stickered Kardex cards were sent to 
the pharmacy after discharge of the patient. So far, Kardex cards were the only 
resource for antimicrobial drug surveillance on individual patient level. In this 
drug delivery system, a conventional antibiotic order form could not be used, 
because the nurses, not the pharmacy technicians, were dispensing the majority 
of the drugs out of a stock. Therefore, an adapted antibiotic order form was 
developed (figure 1). Although it was not only introduced for antibacterial 
drugs, but also for antiviral and antifungal drugs, we preferred to keep the name 
"antibiotic order form" (7), used in the original description. 
The lower part of the antibiotic order form was similar to the original medication 
order strip. After filling in the order on the sheet, the duplicate sticker could be 
pasted on the Kardex card. The text on the order form stickers was printed in 
blue instead of black ink, and therefore the sticker could easily be identified 
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Antibiotic order form with conventional medication order strip. 
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when checking the cards. The order forms were gathered by the ward clerk and 
processed for surveillance by the first author. Prescribers were asked to 
categorize all their prescriptions of antimicrobial drugs as prophylaxis, empirical 
therapy, or directed therapy. For empirical prescriptions, they were asked to 
state the suspected causative microorganism; for directed therapy, they were 
asked for the isolated pathogen. Empirical therapy had to be streamlined to 
directed therapy after 72 hours, and documented by another form. 
Further items to be filled in included patient data, date of prescription, site of 
infection, weight, serum creatinine, and a history of allergy. A limited number of 
formulary antimicrobial drugs and dosage regimens were printed on the form 
and could be ticked off. The prescriber was asked to state his/her reasons to 
deviate from the preprinted antimicrobial drugs and/or dosing regimens. Use of 
the form was voluntary, i.e. delivery of the antimicrobial drugs to the patients 
was not dependent on completion of the form. 
Compliance. 
Compliance (percentage of prescriptions for which an order form was used) was 
measured by checking the Kardex cards as described above. Pharmacy 
technicians identified the patients to whom antimicrobial drugs were prescribed 
on their twice weekly visits to the wards. They scored the total number of 
antimicrobial drug prescriptions and these figures were compared with the 
antibiotic order forms received. When order forms were missing, no further 
action was undertaken. Newsletters provided the physicians with feedback 
about their actual compliance. 
Quantity of use. 
The number of prescriptions is an incomplete estimate of the quantity of 
antimicrobial drug use, as duration of treatment may vary. Therefore, an estimate 
of the prevalence of antimicrobial drug use was made. Twice a week, pharmacy 
technicians scored the number of patients that actually received antimicrobial 
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therapy. The score of one month was related to the number of bed days of that 
month. Thus, the estimate of the prevalence presented is the twice-weekly-
scored number of patients receiving an antimicrobial drug/100 bed days over a 
month. Prescriptions on the forms were quantified according to patient age. The 
distribution of the types of antimicrobial drugs prescribed on the forms was 
calculated. 
Quality of use. 
Data extracted from the antibiotic order forms were used to quantify the sites of 
infection, the microorganisms suspected or isolated, and the reasons to deviate 
from the antimicrobial drugs or the dosages indicated on the form. Prescriptions 
that were categorized as empirical therapy were evaluated separately for 
adequacy of microbiological spectrum, i.e. if the isolated pathogen was 
susceptible to the drug. No attempt was made to evaluate microbiological 
efficacy, i.e. the actual cure rate of infections. 
Results 
Compliance. Acceptance of the antibiotic order form by physicians was high. 
Compliance rose from 58% in the first two weeks after introduction to 76% from 
week five on. However, many forms were not filled in completely. Localisation 
of infection was indicated on 84% forms, and on 73% of those forms, a 
suspected or isolated pathogen was indicated. 
Quantity of use. 
Six hundred and fifty-eight forms with new therapeutic antibiotic prescriptions 
were collected over seven months. The number of patients on antimicrobial 
drugs/100 beddays as scored by the pharmacy technicians was 9.0, 9.8, 8.6, 9.8, 
8.8, 10.6 and 12.8. The number of prescriptions/ 100 bed days according to age 
is given in table 1. 
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Table 1 - Distribution of 564 new prescriptions on antibiotic order forms 




























The frequency distribution of the types of antimicrobial drags prescribed is 
given in figure 2. 
other drugs, not preprinted 
antiviral and antifungal drugs 
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Figure 2 - Frequency distribution of antimicrobial drug types prescribed on 658 
new order forms. 
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Penicillins were the most frequently prescribed drugs (41%), followed by 
cephalosporins (14%) and cotrimoxazole (11%). 
Quality of use. 
In 108 (16%) out of 658 forms the localisation was left blank and they were 
excluded from the analysis. Localisation of the infection and the mentioning of a 
(suspected) pathogen are analysed in the remaining 550 forms (table 2). Of the 
403 forms that showed both localisation of the infection and (suspected) 
pathogen, 51% were categorized as empirical therapy and 49% as directed 
therapy. Fifty-three percent of all 550 prescriptions were made for the treatment 
of respiratory tract infections and urinary tract infections. 
Table 3 shows, as an example, 97 suspected and 37 isolated pathogens cited on 
103 forms to treat respiratory tract infections. 
The prescribers deviated from the proposed antimicrobial drugs in 6% only. 
Overall, alternative drugs and/or alternative dosing regimens were prescribed in 
22%. In the department of nephrology, dosing adaptations amounted to 38%, 
mostly due to renal function impairment. 
Table 2 - Localisation of infections and categorization of 550 new antibiotic order forms 
site of forms suspected* isolatedt no pathogen 
infection pathogen pathogen mentioned 




skin /soft tissue 
abdominal 
bone and joint 







































* categorized as empirical therapy, t categorized as directed therapy 
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A subgroup of 68 consecutive empirical prescriptions was analysed in detail. 
Isolated microorganisms were susceptible to the empirically chosen drug in 
23/31 (74%). The probability that the isolated pathogen was susceptible to the 
empirically started drug was higher when the prescribing physican cited a 
suspected pathogen on the form: Odds ratio 3.1 (95% confidence interval: 0.6-
16.6). However, according to Fisher's exact test, the difference was not 
significant (p=0.23). 
Table 3 - Pathogens (n= 134) as mentioned on 103 antibiotic order forms for 
respiratory tract infections. 
pathogen suspected isolated 





























































3 # (8) 
Total 97 (100) 37 (100) 
* group A; t S. aureus 3x; ft Chlamydia psittaci 2x, Mycoplasma pneumoniae 
2x, Herpes simplex; # Citrobacter, E. coli, Herpes simplex. 
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Discussion 
Over the first half year after the introduction of the order form, surveillance of 
limited parameters of antimicrobial drug use could be done. According to the 
prescribing physicians, incorporation of the conventional medication order in 
the antibiotic order form facilitated its use. The collection and the analysis of the 
data on the forms was much less time consuming for the researchers than former 
analysis by reviews of medical records (see chapter ІП). 
As delivery of antimicrobial drug therapy to the patient was not dependent 
upon the completion of the antibiotic order form, compliance was limited. Higher 
compliance rates may be achieved when use of the form is mandatory (15). 
Nevertheless, with a compliance of 76%, we consider the data extracted from 
the forms as representative for the half year studied. 
The scores of the pharmacy technicians, used as an estimate of the prevalence of 
antimicrobial drug use, allowed for monthly comparisons. There was no decrease 
in consumption over the first seven months. Comparison with consumption data 
before the introduction of the form is more difficult. In a one-month review 
performed two years earlier in the same department, antimicrobial drug 
consumption was accurately quantified with the help of the medication sheets 
(Kardex®). The incidence rate was 4.2 therapeutic courses/ 100 bed days (see 
chapter VIII). The decrease in consumption following use of the form described 
in US hospitals, was probably achieved by the automatic stop of drug delivery 
by the pharmacy after 72 hours for empirical therapy or after the planned 
duration of directed therapy had expired (7). In our setting, the planned 
duration filled in on the forms had no consequences for the actual delivery of 
the drugs to the patient. 
This relatively high compliance with the form on voluntary basis may have 
served the purpose of enhancing quality of prescription. The prescribers used 
almost exclusively the proposed drugs on the form (94%). Moreover, half of the 
other prescriptions were for tuberculostatic drugs, that had been omitted from 
the form. In addition, the order form reminded the prescriber to think of a 
suspected microorganism. It is thought that there is a relationship between the 
164 
quality of prescribing antimicrobial drugs and the knowledge of a (suspected) 
pathogen (16). The degree of appropriateness of empirical therapy of 74% 
compared favorably with the figures of the previous antimicrobial drug review 
before the implementation of the order form. At that time, 67% of the isolated 
pathogens were susceptible to the drug chosen. A suspected microorganism was 
spontaneously mentioned in the medical record in 20 % of empirical courses 
(see chapter VIII). Again, data before and after the introduction of the form are 
not entirely comparable, as, without a form, prescribers were not asked for the 
(suspected) pathogen. Analysing the prescribing practices after introduction of 
the antibiotic order form by the in-depth method used in the review before 
introduction, may provide a better evaluation of the effectiveness of the form. 
We conclude that surveillance of antimicrobial drug use by an order form was 
feasible in this large department of internal medicine. Future usefulness of the 
form will depend on the level of compliance and the availability of personnel 
and support for data processing and intervention. 
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General Discussion 
We measured quantitative use, qualitative use and costs of antimicrobial drugs in 
the main medical and surgical departments of a university hospital between 
1989 and 1993. These departments should be representative for the overall use 
in the hospital. After doubling between 1982 and 1988 (see introduction, p.7), 
hospital antimicrobial drug costs have remained on a fairly constant level over 
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Figure 1 - Drug consumption in the University Hospital Nijmegen 
The relative contribution of antimicrobial drags in the total hospital drug budget 
decreased from 22% in 1989 to 16% in 1992. Total patient days varied less than 
2% per year. 
The in-depth method of the utilization reviews (chapters II, IV and ПІ) was 
very time-consuming, partly due to the lack of computerized pharmacy data on 
individual patients. However, the first review yielded invaluable information on 
logistic pitfalls in prescribing and on psychological motives of doctors, nurses 
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and clerk personnel. We believe that this in-depth approach contributed to the 
successful implementation of the protocols in the departments of surgery. 
Although conducted prospectively, a shortcoming of this type of review is the 
incomplete information provided by the medical record in order to evaluate the 
appropriateness of antimicrobial drag use. Interviewing the prescriber (1) would 
certainly give more information on the rationale behind prescribing. However, 
this approach is even more time consuming, and the review may have in itself an 
effect on prescribing (2). In search of a more economic personnel distribution, 
the reviews were performed with the help of hospital pharmacists in training and 
pharmacy technicians (chapter VIII). The analysis learned that clinical data for 
our evaluation of therapy could only be recorded satisfactorily by a clinician. 
Most other aspects of these studies, on the edge of clinical medicine, 
microbiology, pharmacy, epidemiology, hospital hygiene, management and 
economics could not have been performed without the help of a 
multidisciplinary team. In addition, most skills required for the intervention 
studies had nothing to do with clinical internal medicine. To perform audits of 
this type, the doctor should resemble the ideal infection control doctor described 
by Daschner (3). 
Use of an antibiotic order form can solve part of the personnel support problem 
(4). However, within the Dutch university hospital drug supply system, the 
antibiotic order form was of limited success (chapter VIII-IX). In the future, 
surveillance by order form will be possible if compliance is sufficient (at least 
75%) and if the data on the form are processed regularly. Therefore, logistic 
support of the pharmacy of a form which is made mandatory, is recommended. 
Targeted interventions on duration of empiric therapy or on the use of specific 
drugs will then become possible. 
The consumption figures were lower than those found in the U.S., although 
comparison is often difficult, due to the variety of measurement units employed 
in U.S. studies. Recently, the outcome of the consumption analysis comparing 
hospitals in the Netherlands with neighboring countries was favorable (5). We 
have tried to provide standardized quantitative data by using the unit of defined 
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daily doses/ 100 bed days, as proposed by the WHO Drag Utilization group. 
Even this approach does not give comparable consumption data over time, as 
lists of DDDs are regularly updated. Lists of DDD are published regularly in the 
Nordic Statistics on Drugs (6). An example illustrates this problem. The DDD for 
parenteral quinolones, cephalosporins and even benzylpenicillin have been 
adapted between 1985 and 1995. For a few drugs, we had to use 2 different 
DDDs for the studies in surgery and internal medicine. 
In internal medicine, we saw that due to tertiairy care, the contribution of 
antiviral and antifungal drugs to the total antimicrobial drug consumption and 
costs is considerable. 
The cost of antimicrobial drugs involves considerably more than the purchase of 
the drug. We performed a global cost calculation (true cost calculation) for 
antimicrobial drugs tailored to the Dutch hospital situation (chapter III). Cost 
comparisons and cost savings calculations were all done by taking into account 
the extra costs of administering and monitoring (chapters IV and VIII). 
In surgery, 30% of consumption was for prophylaxis and the first review 
showed that, for prophylaxis, the indication, the timing and the duration were 
not up-to date. Suboptimal timing was confirmed in a peripheral hospital. 
Organizational aspects seemed of primary importance. The implementation of 
protocols was very effective. Different parameters of quality improved and 
consumption decreased. 
As correctly predicted by our first evaluation, improvement in the quality of 
therapeutic courses resulted in an increase in antimicrobial drug consumption for 
fewer patients, both in surgical and medical departments, and therefore in a 
higher total cost per bed day. 
In internal medicine, we also found suboptimal quality. There was a certain 
degree of underutilization in severe infections: empiric therapy was not effective 
against all cultured pathogens, the dosage was often too low, the duration of 
therapy too short. On the other hand, many short courses with oral drugs were 
judged unnecessary. We intervened with educational programs and an 
antibiotic order form. These combined strategies resulted in an improvement in 
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quality. Less patients were prescribed antimicrobial drugs. Patients with severe 
infections were treated with drugs with a broader spectrum, higher doses and a 
longer duration of therapy. This intervention resulted in higher expenses for 
antimicrobial drugs. 
The effect of an antibiotic policy according to the principles of "good 
antimicrobial drug prescribing" (chapter I) on patient care is not easily measured. 
As in comparative clinical trials of antimicrobial drug therapy that use clinical 
outcome of infectious diseases as a measure of effect, large numbers of patients 
are needed to show a difference in outcome. An example is the reduction of 
postoperative wound infections as an effect of optimizing the timing of 
antimicrobial drug prophylaxis (7). However, if the hospital has no systematic 
and computerized registration of wound infections, these data are lacking. An 
indirect measure of the improved quality is the trend over time of the median 
length of hospital stay in surgical departments with a constant pattern of 
surgical procedures. Another indicator can be the number of nosocomial 
infections that need to be treated with antimicrobial drugs. In our opinion, there 
is no need to prove in every hospital that the application of the principles of 
good antimicrobial drug prescribing results in a better outcome for the individual 
patient. 
The studies in the present thesis have been done against a background of 
strong national policy and tradition of prudent antimicrobial drug use. In the 
Netherlands, socio-economic and marketing pressures which lead to 
inappropriate use are controlled and physicians are educated in this tradition. 
This has been recently documented in several studies. Stobberingh studied 
Dutch guidelines for prescription (8). From the study of Janknegt we know that 
Dutch university hospitals have a low consumption of antimicrobial drugs 
compared with German and Belgian hospitals. From the EPIIC study (9) we 
know that bacterial resistance in ICU's in the Netherlands compares favourably 
with other European countries. It has been suggested that strong policies are 
the cause of the low rates of resistance (10). 
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Recommendations 
Guidelines to improve the use of antimicrobial drags in hospitals developed by 
the Infectious Diseases Society of America (11) are still applicable. Every 
hospital should have its antibiotic committee. Formularies should be adapted to 
the local antibiotic susceptibility data. The formularies should be stringent so 
that newly marketed drugs are automatically restricted. Utilization reviews and 
interventions have to be done by multidisciplinary teams. Antimicrobial drug 
reviews in referai hospitals should include antiviral and antifungal drugs. Each 
hospital should chose the appropriate control method(s) available (12). Full 
support of the hospital board is a prerequisite for success. Until now, the most 
powerful tool for a change in policy has been the prediction of antimicrobial 
drug cost reduction in the presence of budget exceedings. 
Drug utilization reviews and intervention methods in surgery 
Protocols are the most successful method of intervention in surgery if prepared 
with the co-operation of the surgical staff. Prophylaxis guidelines should be 
clear and regularly updated. With the help of computer software, prophylaxis 
can be monitored at pharmacy level. The program used in the studies of this 
thesis was originally developed for Apple Macintosh computers by the authors; 
a revised version has been developed for use under Ms-Windows by BJ 
Kullberg & M Roomer of Nestor BV, The Netherlands, on behalf of a working 
party of hospital pharmacists, infectious disease physicians and consultant 
microbiologists. 
For a utilization review of antimicrobial prophylaxis, a suitable sample size 
should be chosen, depending on local situation. In general surgery, actually 
30% to 40% of all operations can be allocated to categories for which 
prophylaxis is deemed appropriate. Thus, to gather enough data on the 
presciptions of 100 prophylactic courses, a consecutive sample of 250 to 300 
operations is needed. Collection of the data can be done by a well-trained 
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pharmacy technician or infection control nurse. The evaluation of antimicrobial 
prophylaxis for surgical procedures can be performed by the hospital pharmacist 
using the flow chart (chapter II). The help of a surgery staff member is advisable 
to classify the procedures into the correct categories (i.e. clean, contaminated..) 
in order to judge appropriateness of prophylaxis and compliance with 
guidelines. 
After an initial review indicates that prophylaxis can be optimized, alternative 
regimens should be proposed. Projected cost savings can be calculated. The 
new protocols have to be implemented. The result of these interventions should 
be evaluated in a repeated survey. Pharmacy technicians can detect protocol 
violations during their routine work on the wards and correct and/or report them 
as a continuous surveillance, or collect the data on prescriptions in the computer 
database for later evaluation. 
Utilization reviews and intervention methods in internal medicine 
Education of physicians in the matter of infectious diseases and antimicrobial 
therapy, and peer reviews are the best accepted methods of intervention in 
internal medicine. However, education as sole intervention has not always been 
successful (13). An antibiotic order form will have a high compliance if it is made 
mandatory and controlled by the pharmacy. It will be more effective if 
computerized pharmacy data allow for targeted interventions. At that time, 
automatic stop orders can be applied, controlling for the duration of empiric 
therapy and for streamlining of therapy. In referai and training hospitals with 
complicated cases, a structured consultancy service of infectious diseases 
specialists and consultant microbiologists is probably the best tool to optimize 
the quality of antimicrobial drug courses. 
It would be a challenge to try the interventions used in this thesis in hospitals 
with major antimicrobial resistance and/or hospitals where overconsumption of 
antimicrobial drugs is still a problem. If developing countries strengthen their 
policies to allow the application of these methods, it is anticipated that major 
cost savings and reduction in resistance will ensue. 
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Summary 
This thesis is composed of studies on the use of antimicrobial drugs in a Dutch 
University Hospital. Most of the descriptive studies have been followed by an 
intervention to improve quality of use, and a second review has been 
performed to measure the effect of the intervention in terms of quantity, quality 
and costs of antimicrobial drug courses. 
SECTION A Background and methodology 
Chapter I gives as an introductory background the principles of good 
antimicrobial drug use. How antimicrobial drug therapy differs from other kinds 
of drug therapy and what physicians should consider before starting a 
treatment. 
Chapter Π describes the method that has been developed in order to evaluate 
quality of use of antimicrobial drugs, based on established criteria. The method 
allows for evaluation of each individual parameter associated with antimicrobial 
drug use. We developed a flow chart which facilitates the sorting of 
prescriptions into categories, systematizes and accelerates the review. The 
evaluation is performed by two independent reviewers qualified in infectious 
diseases, who formulate alternative agents in case of inappropriate antimicrobial 
drug use. 
Chapter III deals with the method of cost-identification analysis which was 
used in the quality-of-use studies. To maximize cost containment, efforts to 
obtain cost savings have to be directed to the following cost components : 
costs of acquisition, costs of preparation and administration, and costs of 
monitoring of antimicrobial drugs. Purchase contract prices for antimicrobial 
drugs vary between hospitals and they are invariably lower than wholesale 
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prices. However, to allow generalization of our calculation results to other 
Dutch hospitals, we chose wholesale purchase prices of antimicrobial drugs and 
national prices for salaries and hospital costs. The result of global cost 
comparison contributes to the decision to include new drugs into the hospital 
formulary or to replace older ones. 
SECTION В Surveys in surgical departments 
In chapter IV we describe how new guidelines were implemented in surgical 
departments, following a one-month prospective review of consecutive 
antimicrobial drug use. The review was repeated after 2 years. Total number of 
patients (766 vs 744) and operations (542 vs 522) were similar. In both study 
periods, one third of the patients were prescribed antimicrobial drugs. 
Prophylactic drug consumption decreased from 0.75 to 0.53 DDD/operation. 
Compliance with guidelines improved from 32% to 79%. Duration of 
prophylaxis > 24 hours decreased from 21% to 8%. Quality of prescribing 
improved, as evaluated by the method described in Chapter II. For prophylaxis, 
cost savings amounted to 57%. Better quality of therapeutic courses was 
associated with a cost increase of 15%. Indicators of satisfactory outcome with 
the new policy were a stable median length of stay and a reduction in the 
number of nosocomial infections/100 bed days treated with antimicrobial drugs. 
Chapter V is a prospectively conducted audit of consecutive requests for 
microbiological analysis sent to the laboratory by a department of orthopaedic 
surgery during a six weeks period. The majority of the specimens were surgical. 
The microbiology analysis of these specimens is crucial in order to establish the 
correct diagnosis and appropriate choice of antimicrobial drugs. In a formal 
evaluation performed by 2 consultant microbiologists, the majority of the 
requests were classified as definitely appropriate. Collection, handling and 
transport was not optimal. No request was considered unjustified. A certain 
degree of underutilization, inappropriate sampling for anaerobic culture and a 
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prolonged transport time to the laboratory were found. Analysis of compliance 
with an existing protocol for prosthetic joint revision revealed similar problems. 
Chapter VI shows how the anaesthetist plays a key role in surgical 
antimicrobial prophylaxis. The staff of 44 anaesthetists and residents was 
interviewed by means of a questionnaire about the practice of surgical 
prophylaxis. Response rate was 82%. The anaesthetists' way of administering 
surgical prophylaxis was rather uniform and economic. Communication 
between surgeon and anaesthetist on the subject of prophylaxis was reported 
to be poor. In two out of six operating departments, orders of prophylaxis 
transmitted at or after induction accounted for more than 80%. Seventy seven 
percent of the responders asked the surgeon if prophylaxis was necessary if 
they were in doubt; 20% responded that they checked it systematically. There 
was an association between poor communication reported by the anaesthetists 
and the late administration (after incision) of prophylactic antibiotics. The 
inquiry proved useful in the process of optimizing surgical prophylaxis in our 
hospital. 
Chapter VII describes the considerable improvement of the timing of 
prophylaxis in the surgical departments of the university hospital where the 
intervention (described in chapter IV) was carried out. Optimal timing 
(administration within one hour before incision) increased. Before the 
intervention, seven out of 16 prophylactic doses were given after inflation of 
the tourniquet. After the intervention all doses of prophylactic antibiotics were 
administered before inflation of the tourniquet. Initially, the intervals of 
multidose prophylaxis varied widely. Single dose prophylaxis increased from 
21% to 78% in department A and from 31% to 85% in department B. 
SECTION С Surveys in internal medicine 
Chapter Ш 
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Following an initial prospective quality-of-use review of all consecutive 
antimicrobial drag courses in the department of internal medicine during four 
weeks, an educational programme was conducted and an update of the 
formulary was issued. In search for an appropriate surveillance method, an 
antibiotic order form was introduced in two out of three units. Four years after 
the first review, an identical survey was done. Quality was evaluated using the 
method described in chapter II. As correctly predicted by our first evaluation, 
improvement in quality resulted in an increase in antimicrobial drug 
consumption for fewer patients (21% vs. 31%), and a higher total cost per bed 
day. One year after introduction, the compliance with the antibiotic order forms 
on voluntary basis in two units was 77% and 50% respectively. With support 
of the hospital pharmacy, i.e. by making the form mandatory and by taking 
actions in case of noncompliance, the form could be a useful tool for 
antimicrobial drug surveillance in European hospitals in the future. 
Chapter IX describes in detail the easy-to-use antimicrobial ordering sheet 
(antibiotic order form) that was introduced in the department of internal 
medicine (chapter VIII). An antibiotic order form may improve the quality of 
prescriptions by increasing the awareness of the physician of the antimicrobial 
spectrum needed (i.e. which microorganism is expected in a given patient), the 
desired duration of treatment, the potential need to adjust dosage, and the 
potential allergy of the patient to the drug. Furthermore, such an antibiotic 
order form facilitates prospective evaluation of both the quantity and the 
quality of prescribing practice. An overall compliance on voluntary basis of 
76% was reached in the first seven months. Data retrieved from the antibiotic 
order forms could be used for surveillance. We concluded that this antibiotic 
order form was feasible in a large department of a university hospital. 
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Samenvatting 
Dit proefschrift is samengesteld uit studies naar het gebruik van antimicrobiële 
middelen in een academisch ziekenhuis in Nederland. De meeste descriptieve 
studies werden gevolgd door een interventie die tot doel had de kwaliteit van 
het gebruik te bevorderen. Daarna werd een tweede registratie uitgevoerd om 
het effect van de interventie te meten. 
DEEL A Achtergrond en methoden 
Hoofdstuk I schetst als inleidende achtergrond de principes van goed gebruik 
van antimicrobiële middelen. Hoe de behandeling met antimicrobiële middelen 
verschilt van andere vormen van farmacotherapie en waaraan artsen moeten 
denken voor zij deze middelen voorschrijven. 
Hoofdstuk II beschrijft de methode die werd ontwikkeld om de kwaliteit van 
het gebruik van antimicrobiële middelen te beoordelen. Deze methode is 
gebaseerd op gevestigde criteria. De methode laat toe elke parameter die van 
belang is voor antimicrobiële therapie afzonderlijk te evalueren. Er werd een 
stroomdiagram ontwikkeld, dat het sorteren in categorieën van goed gebruik 
vergemakkelijkt. Het stroomdiagram brengt systematiek in de beoordeling en 
versnelt het evaluatieproces. De beoordeling wordt uitgevoerd door twee 
onafhankelijke experts op het terrein van infectieziekten. In die behandelingen 
waar het gebruik als suboptimaal wordt ervaren, moeten zij alternatieve 
behandelingsschema's voorstellen. 
Hoofdstuk III beschrijft de methode van kosten-identificatie die toegepast 
werd in de gebruiksstudies. Om tot een maximale kostenbesparing te komen, 
moeten de inspanningen gericht zijn tegen alle componenten van een integrale 
kostenberekening. Het betreft de aankoopkosten, de kosten van klaarmaken 
180 
en toedienen, en de kosten van monitoring van toxiciteit. Aankoopprijzen via 
contracten variëren sterk tussen de verschillende ziekenhuizen, en zijn meestal 
lager dan de groothandelsprijzen. Om vergelijking met andere Nederlandse 
ziekenhuizen mogelijk te maken, hebben wij als aankoopprijs de 
groothandelsprijzen Brocacef gehanteerd, en nationale cijfers gebruikt voor de 
salarissen en ziekenhuiskosten. Het resultaat van de integrale kosten 
berekening kan de beslissing om nieuwe geneesmiddelen in het 
ziekenhuisformularium op te nemen, of om oudere middelen te vervangen, 
beïnvloeden. 
DEEL В Studies ín de chirurgische afdelingen 
In hoofdstuk IV beschrijven we hoe na de rapportage van een eerste 
prospectieve gebruiksstudie, nieuwe richtlijnen geïmplementeerd werden in 
chirurgische afdelingen. De registratie van het gebruik werd na 2 jaar herhaald. 
Het totale aantal patiënten (766 vs 744) en het aantal ingrepen (542 vs 522) 
van beide metingen was vergelijkbaar. In beide onderzoeksperioden van een 
maand werd aan een derde van de patiënten antimicrobiële middelen 
voorgeschreven. Het gebruik van profylaxe daalde van 0.75 tot 0.53 
DDD/ingreep. Na de interventie hield men zich ook beter aan de richtlijnen, in 
79% versus 32% voor de interventie. Profylaxe langer dan 24 uur werd in 8% 
toegepast, terwijl dat in het eerste onderzoek 21% bedroeg. Ook volgens de 
beoordelaars die de methode uit hoofdstuk II hanteerden, was de kwaliteit van 
voorschrijven verbeterd. In de profylaxe werd een kostenbesparing van 57% 
gerealiseerd. De betere kwaliteit van de therapeutische behandelingen ging 
echter gepaard met een kostenstijging van 15%. Indicatoren van een 
bevredigend klinisch resultaat met het nieuwe beleid waren een stabiele 
mediane ligduur en een daling van het aantal nosocomiale infecties/100 
beddagen dat behandeld moest worden met antimicrobiële middelen. 
Hoofdstuk V is een prospectieve audit van opeenvolgende aanvragen voor 
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microbiologisch onderzoek ingezonden door een afdeling orthopaedie, en dit 
over een periode van 6 weken. Het betrof in de meerderheid chirurgisch 
verkregen monsters. De microbiologische analyse van deze monsters is 
essentieel om de correcte diagnose te stellen en de adekwate therapie te kiezen. 
In een gestandaardiseerde evaluatie door 2 artsen-microbioloog werd de 
meerderheid van de aanvragen als volledig juist geclassificeerd. Geen enkele 
aanvraag werd als overbodig geclassificeerd. Onvoldoende benutten van de 
diagnostische mogelijkheden van het laboratorium, een niet optimale 
bemonstering voor anaerobe kweken en een te lange transporttijd naar het 
laboratorium waren de resterende problemen. Analyse van de compliance met 
een bestaand protocol voor revisie van gewrichtsprothesen toonde dezelfde 
tekortkomingen als bij de niet protocollaire aanvragen. 
Hoofdstuk VI toont hoe de anaesthesioloog een sleutelpositie heeft in de 
chirurgische antimicrobiële profylaxe. Een schriftelijke enquête bij 44 stafleden 
en assistenten van een afdeling anesthesiologie had een respons van 82%. De 
toedieningswijze van keuze voor de profylaxe bleek éénvormig en 
economisch. De communicatie tussen de chirurg en de anaesthesioloog over de 
profylaxe werd door de anesthesiologen als onvoldoende ervaren. In 2 op 6 
operatiekamers werden de instructies voor profyaxe in meer dan 80% pas 
gegeven op het ogenblik van de inleiding van de anaesthesie of nog later. 
Zevenenzeventig percent van de responders vroegen de chirurg of profylaxe 
nodig was als ze zelf twijfelden; 20% antwoordde dat ze er systematisch om 
vroegen. Er was een verband tussen de gebrekkige communicatie in sommige 
operatiekamers zoals die gerapporteerd werd door de anaesthesiologen, en de 
laattijdige toediening (na de incisie) van de profylactische antibiotica bij 
metingen in diezelfde operatiekamers (hoofdstuk VII). De enquête leverde snel 
een goed inzicht in de opinies en het medisch handelen van deze grote groep 
artsen. De resultaten werden gebruikt bij het reorganiseren van de profylaxe. 
Hoofdstuk VII beschrijft de belangrijke verbetering van de timing van de 
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profylaxe in de operatiekamers van het academisch ziekenhuis waar de 
interventie (beschreven in hoofdstuk IV) uitgevoerd werd. De antimicrobiële 
middelen werden vaker in de optimale periode (binnen een uur voor incisie) 
toegediend. Vóór de interventie waren 7 op 16 profylactische doses pas 
toegediend na het aanleggen van de bloedleegte. Na de interventie werden alle 
injecties voor profylaxe toegediend voor het opblazen van de 
bloedleegteband. Bij de eerste registratie bestond er een grote variatie in de 
intervallen van de injecties bij profylaxe met meerdere doses. Vóór de 
interventie werden eenmalige doseringsschema's voor profylaxe slechts in 21% 
(afdeling A) en 31% (afdeling B) toegepast. In het naonderzoek was dit 
toegenomen tot respectievelijk 78% en 85% . 
DEEL С Studies in de interne geneeskunde 
Hoofdstuk Ш 
In de interne geneeskunde werd ook gestart met een registratie van alle 
opeenvolgende behandelingen met antimicrobiële middelen gedurende vier 
weken. De interventies bestonden uit een vernieuwing van het formularium, 
een educatief programma in de vorm van wekelijkse casusbesprekingen, en een 
antibioticaformulier dat slechts in twee op drie afdelingen werd geïntroduceerd. 
Vier jaar na het eerste onderzoek werd een identieke registratie uitgevoerd. De 
kwaliteit werd door de twee experts beoordeeld volgens de methode 
beschreven in hoofdstuk II. Zoals de eerste evaluatie kon voorspellen, 
resulteerde een verbetering in de kwaliteit in een toename van het gebruik van 
antimicrobiële middelen voor een kleiner aantal patiënten (21% versus 31%), en 
in hogere kosten per beddag. Een jaar na introductie van het 
antibioticaformulier was de compliance op vrijwillige basis in de twee 
afdelingen respectievelijk 77% en 50%. Met de logistieke steun van de 
ziekenhuisapotheek, bv. door het formulier verplicht te maken en door acties te 
voeren in het geval van niet invullen van het formulier, kan het 
antibioticaformulier bruikbaar zijn voor continue registratie van het gebruik 
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van antimicrobiële middelen in Europese ziekenhuizen. 
Hoofdstuk IX beschrijft in detail het antibioticaformulier dat gebruikt werd in 
de afdelingen van interne geneeskunde (hoofdstuk VIII). Een 
antibioticaformulier kan de kwaliteit van het voorschrijfgedrag beïnvloeden 
door de voorschrijver te vragen om een vermoedelijke verwekker te noemen en 
hem zo te doen nadenken over het benodigde spectrum van het 
antimicrobieel middel. Verder verhoogt het de alertheid op de mogelijke 
noodzaak om de dosering aan te passen en op mogelijke allergieën. Het vraagt 
de arts meteen een plan op te maken over de vereiste therapieduur. Het 
formulier vergemakkelijkt de prospectieve registratie van zowel kwantitatieve 
als kwalitatieve aspecten van het gebruik van antimicrobiële middelen. In de 
eerste zeven maanden werd een compliance op vrijwillige basis van 76% 
bereikt. De gegevens van de formulieren waren bruikbaar voor continue 
registratie. Het gebruik van het antibioticaformulier was haalbaar in deze grote 
afdeling in een academisch ziekenhuis. 
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dr. R van Fürth) met een beurs van de Belgische Rotary. Van 1989 tot 1992 
werkte zij als internist-onderzoeker in de afdeling algemene interne 
geneeskunde van het Academisch Ziekenhuis Nijmegen (hoofd: Prof. dr. A van 
't Laar). Het onderzoek in het AZN, onder leiding van Prof. dr. JWM van der 
Meer, resulteerde in dit proefschrift. 
Sinds 1992 is zij aangesteld als internist-infectioloog in de afdeling klinische 






behorend bij het proefschrift 
Optimizing antimicrobial drug utilization. 
Studies and interventions in a university hospital. 
Nijmegen, 28 mei 1996 
Inge С. Gyssens 

Stellingen 
1. De wetenschappelijke basis voor een optimale chirurgische 
antibioticaprofylaxe is al dertig jaar bekend; dit wil niet zeggen dat ze 
optimaal wordt uitgevoerd (dit proefschrift). 
2. De antibioücacommissie dient overleg te plegen met de anesthesiologen 
bij het opstellen en implementeren van richtlijnen voor chirurgische 
profylaxe (dit proefschrift). 
3. Het Antibioticaformulier zal in een Nederlands academisch ziekenhuis pas 
een maximum complianüe bereiken als het beheerd en gecontroleerd wordt 
door de apotheek (dit proefschrift). 
4. Bij onderzoek naar het gebruik van antimicrobiële middelen in 
academische ziekenhuizen moet men het gebruik van antivirale en 
antifungaie middelen in het onderzoek betrekken (dit proefschrift). 
5. Het verbeteren van de kwaliteit van het gebruik van antimicrobiële 
middelen leidt niet tot kostenbesparing indien er sprake is van 
onderbehandeling van ernstige infecties (dit proefschrift). 
6. De Verenigde Staten zouden op gebied van antibioticabeleid veel kunnen 
leren van landen waar de resistentie tegen antimicrobiële middelen beperkt 
is ( JWM van der Meer & EH van de Lisdonk. CID 1995;21:1069). Een 
commentaar op hoofdstuk Г van dit proefschrift als: "The manuscript 
suffers from the following shortcoming: the study was carried out in a 
hospital in the Netherlands", door een referee van het tijdschrift Clinical 
Infectious Diseases, stemt niet tot optimisme. 
7. It is possible for women to combine motherhood with a fulfilling career in 
academic medicine, but it is difficult, and most such women believe that 
motherhood slows the progress of their careers. (W Levinson, SW Tolle 
& С Lewis. Women in academic medicine. N Engl J Med 1989; 321: 
1511-7). 
8. Een vrouw die in deze westerse samenleving wil slagen in een carrière 
heeft enkele troeven nodig: organisatievermogen, flexibiliteit, en een 
geëmancipeerde man. 
9. Het definitief van de weg halen en tot schroot verwerken van een miljoen 
personenwagens zal meer bijdragen tot de volksgezondheid dan het 
afslachten van een miljoen Britse koeien. 
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